ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	51/1485	73/6030	3.3279139143627e-16	1.8203689111564e-13	1.49580972782408e-13	6356/6357/6358/6361/6362/6363/6347/6364/6367/6369/6370/10344/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/10148/3458/3586/3589/3605/3606/29949/3552/3553/3557/51561/11009/90865/3569/4049/4312/4314/4318/5008/5196/6696/7124/10673	51
WP2806	Complement system	47/1485	75/6030	2.44948830425535e-12	6.69935051213838e-10	5.50490266272124e-10	133/335/715/716/717/718/720/722/728/27202/729/811/958/1604/966/22918/629/1675/3426/5199/1378/2159/2160/2214/2219/2357/2769/3383/3384/3673/3687/3689/3690/3818/3911/3915/5648/5329/5806/6401/6402/6403/6404/710/6696/7097/7454	47
WP5055	Burn wound healing	52/1485	97/6030	6.47315187615026e-10	1.1802713587514e-07	9.69837140742512e-08	8038/6347/57124/1139/1265/1277/1278/2919/3579/2006/2200/2261/60674/3082/3383/3552/3553/3569/3624/3791/3853/3956/23643/440823/407024/4312/4322/4313/79148/4314/4318/100463486/64332/64127/5159/6282/6280/6423/6678/6876/7042/7043/7076/7096/7097/7099/51311/54106/3371/7124/7128/7431	52
WP5218	Extrafollicular B cell activation by SARS-CoV-2	39/1485	65/6030	1.18521619425025e-09	1.62078314563721e-07	1.33180872353909e-07	57379/604/718/720/6363/958/969/973/941/3732/1378/10148/2113/83416/1880/29851/3433/8519/3455/3458/100885789/3586/3569/3662/9636/3687/3689/4240/5133/639/5788/6402/57823/6776/30009/7099/7124/10673/7494	39
WP5115	Network map of SARS-CoV-2 signaling pathway	83/1485	190/6030	4.13331527914465e-09	4.52184691538424e-07	3.71563289304161e-07	59272/183/335/350/8542/332/684/11119/715/716/84433/838/841/6356/6347/6364/6367/10344/6348/6351/6355/891/10666/983/1051/629/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/54541/84985/2247/2534/51512/3091/3122/3123/3429/10964/8519/10410/3458/3486/3586/3605/3606/8807/3552/3553/90865/3569/10379/3699/3717/3726/116844/64386/4791/22861/114548/4939/5196/5743/6241/6288/6289/6403/5054/6772/7124/7173/7216/7535	83
WP3624	Lung fibrosis	32/1485	52/6030	1.56085211346162e-08	1.42297684343917e-06	1.16926991657563e-06	23250/6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/57105/1906/2006/2246/2247/2252/26585/3082/3553/3569/4313/4318/4502/5155/5328/5806/6498/6696/7015/7076/7124	32
WP2865	IL1 and megakaryocytes in obesity	18/1485	23/6030	9.30071310440729e-08	7.26784295444398e-06	5.97203683546152e-06	6347/1232/2149/2205/1839/3383/3458/3606/3553/3554/4318/114548/7941/6280/8991/7076/7096/7097	18
WP2911	miRNA targets in ECM and membrane receptors	17/1485	22/6030	2.99383629803657e-07	2.0470355687825e-05	1.68206328850212e-05	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/3672/22801/3694/3910/3913/3915/7058	17
WP2328	Allograft rejection	39/1485	76/6030	4.18712343379353e-07	2.54484057587229e-05	2.09111310670156e-05	5243/185/23743/717/718/720/721/729/841/6363/940/958/1604/941/942/1289/1493/6373/4283/50943/10578/3002/3108/3112/3119/3122/3123/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124/7431	39
WP2877	Vitamin D receptor pathway	62/1485	143/6030	5.43273350644552e-07	2.9717052280257e-05	2.44187074447604e-05	5243/11096/147/240/248/604/768/838/875/898/958/1029/1030/634/9075/1493/1594/1559/1565/29785/1576/168002/1673/11221/1946/50486/727936/3091/3123/3294/3486/3488/9173/3662/3684/3726/5653/3827/126364/4600/5368/639/5744/10125/6273/6279/6280/1992/10568/219855/25928/6696/6699/79689/412/6822/7042/7056/7078/7128/4982/54210	62
WP558	Complement and coagulation cascades	28/1485	48/6030	6.10640780300818e-07	3.03655006204134e-05	2.4951541931909e-05	715/716/717/718/721/728/729/1604/629/1675/3426/1191/1378/2159/2149/2152/2155/3818/3827/5648/5328/5329/5624/5054/5345/710/7056/7450	28
WP619	Type II interferon signaling	22/1485	34/6030	8.33631462719222e-07	3.79997008422845e-05	3.12246170685182e-05	4261/3627/4283/1536/2633/3383/3433/3458/3553/3659/3662/10379/9636/3717/4843/5698/5967/8651/9021/6688/6772/6890	22
WP5198	Inflammatory bowel disease signaling	22/1485	35/6030	1.72477320842079e-06	7.25731496158594e-05	5.96338591089618e-05	50943/3108/3458/3586/3594/3595/3606/8807/3552/50615/51561/3569/4772/64127/6097/6772/6774/6775/30009/7097/7099/7124	22
WP5090	Complement system in neuronal development and plasticity	43/1485	93/6030	4.04901572965109e-06	0.000158200828865653	0.000129994715530903	57194/23250/57198/148229/715/716/717/718/720/721/722/725/728/27202/729/843/841/1604/966/629/1675/3426/5199/1191/10584/1378/286204/6376/9787/2219/8547/3458/3684/3685/3687/3689/3690/5648/4240/5359/710/7042/7043	43
WP455	GPCRs, class A rhodopsin-like	51/1485	118/6030	6.14814111511608e-06	0.000224202212664567	0.000184228509203829	1238/51554/134/147/150/185/187/27202/1230/729230/1232/1233/1237/10803/1131/3577/3579/2833/10800/57105/1909/2149/2151/9002/2867/2357/2358/2842/2828/8477/8111/54329/8843/3274/3363/1241/4543/5540/27334/53829/9934/5030/5031/5724/5729/5737/5739/266747/6751/6752/56670	51
WP4891	COVID-19 adverse outcome pathway	11/1485	13/6030	9.22259817489208e-06	0.00030462534095691	0.000250312750098337	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	13/1485	17/6030	1.00242342545236e-05	0.00030462534095691	0.000250312750098337	6347/958/3383/3553/5196/6401/6403/6404/7042/7043/7097/7099/7412	13
WP691	Tamoxifen metabolism	13/1485	17/6030	1.00242342545236e-05	0.00030462534095691	0.000250312750098337	1545/1557/1558/1559/1565/1576/2326/2328/6817/6822/54575/54657/7364	13
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	96/1485	265/6030	1.09891606355092e-05	0.000316372150927554	0.000259965185117032	10000/285/1101/1302/1277/1278/1280/1281/1282/1284/1286/1289/1290/50509/1292/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/51764/2786/3082/3091/7184/3455/3559/3560/3563/3575/22801/3673/3678/3655/3679/8516/3683/3685/3687/3689/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4843/4846/5008/9180/5155/5159/5209/5210/5228/23035/5293/23533/10891/5522/5523/5618/6513/6514/6515/6696/7010/7058/3371/7424/7450	96
WP453	Inflammatory response pathway	17/1485	26/6030	1.25328560500792e-05	0.000342773612969666	0.000281659449125464	940/958/941/942/1277/1278/1281/3458/3559/3560/3568/3911/3913/3915/3918/7133/7535	17
WP129	Matrix metalloproteinases	16/1485	24/6030	1.57899480543934e-05	0.000411290551702533	0.000337960291690525	4312/4319/4321/4322/4323/4327/4313/10893/64386/79148/4314/4316/4318/7076/7078/7124	16
WP4493	Cells and molecules involved in local acute inflammatory response 	12/1485	16/6030	3.15302563552521e-05	0.000761566419080942	0.000625784395165135	718/729/3383/3552/3569/3683/3689/3827/6403/6404/7124/7412	12
WP2882	Nuclear receptors meta-pathway	95/1485	268/6030	3.33014266986095e-05	0.000761566419080942	0.000625784395165135	5243/1244/64240/64241/51/177/51129/335/345/8553/330/874/6347/6364/983/8824/23491/1545/1557/1559/1576/1551/66002/1907/54566/1969/2168/9982/2289/2938/2939/2947/2949/1839/3082/3458/3589/3553/117283/3726/23764/4199/4240/4791/1728/8431/9971/9970/3084/5105/5142/5155/5166/5460/10891/9588/22949/5743/6286/6319/6397/5272/1836/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/8140/5552/27286/6774/2040/6817/6822/7042/7056/7124/7128/84951/1831/54657/54578/7364	95
WP5063	FOXP3 in COVID-19	11/1485	14/6030	3.34142487348128e-05	0.000761566419080942	0.000625784395165135	940/941/942/50943/3559/3560/3569/3572/3575/6774/6776	11
WP5088	Prostaglandin signaling	17/1485	28/6030	5.12540989977109e-05	0.00112143968606991	0.000921494748295686	834/6347/6348/729230/940/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	17
WP530	Cytokines and inflammatory response	13/1485	19/6030	6.85161871097129e-05	0.00144147516726973	0.00118447011724079	1437/1440/2919/2920/3122/3123/3458/3586/3589/3552/3553/3569/7124	13
WP4172	PI3K-Akt signaling pathway	97/1485	280/6030	7.697528969123e-05	0.00155946235041122	0.0012814210018774	10000/285/672/898/1101/1277/1278/1280/1282/1284/1286/1291/1292/1293/256076/131873/1297/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/10681/51764/2786/3082/7184/3455/3559/3560/3563/3569/3575/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4846/5008/9180/5105/5155/5159/5228/23035/118788/5293/8503/23533/29941/5522/5523/5618/10110/6696/7010/7058/7097/7099/3371/7424/7450	97
WP4494	Selective expression of chemokine receptors during T-cell polarization	15/1485	24/6030	8.96114923759954e-05	0.00175062451177391	0.0014385002723515	6348/6351/1230/729230/1232/1233/940/1437/2833/3458/3594/3595/8809/7042/7043	15
WP2849	Hematopoietic stem cell differentiation	23/1485	46/6030	0.000167788051607372	0.00308273765709971	0.0025331068595816	91/947/4261/1437/1440/10320/3552/3553/3569/3690/51176/4005/4582/3071/4778/399/23541/6688/6776/7068/7173/23650/7409	23
WP4969	RAS and bradykinin pathways in COVID-19	15/1485	25/6030	0.000173241493635432	0.00308273765709971	0.0025331068595816	1636/59272/183/185/1576/3552/3553/3816/3818/3827/4846/4881/5054/710/7124	15
WP4538	Regulatory circuits of the STAT3 signaling pathway	33/1485	75/6030	0.000174707252961775	0.00308273765709971	0.0025331068595816	185/1271/1438/1439/1441/1844/2149/2151/9002/2690/3455/3587/3595/3601/50615/9466/3559/3560/3563/3568/3572/3575/3717/3718/5600/6300/9180/5159/5579/5788/80854/9021/6774	33
WP5033	Genes associated with the development of rheumatoid arthritis	12/1485	18/6030	0.000193561126209521	0.00320842230413964	0.00263638280355552	958/4261/1493/3123/3559/3572/3685/23569/26147/6583/6775/7185	12
WP545	Complement activation	12/1485	18/6030	0.000193561126209521	0.00320842230413964	0.00263638280355552	715/716/717/718/720/721/729/1604/629/1675/5199/5648	12
WP3617	Photodynamic therapy-induced NF-kB survival signaling	18/1485	33/6030	0.00021164700198395	0.00340502676721238	0.00279793405099526	597/330/332/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/4791/5743/6401/7124/7412	18
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	16/1485	28/6030	0.00023241571491156	0.00363232560161781	0.00298470707570635	6347/29126/941/942/1493/3627/3559/3560/4791/5133/8651/6774/7042/7043/7099/51311	16
WP3937	Microglia pathogen phagocytosis pathway	20/1485	39/6030	0.000287823180713424	0.00437331332917342	0.00359358181767931	10095/1536/2207/2209/3055/3684/3689/4067/653361/4688/4689/3071/5293/8503/5336/5880/27036/54210/7409/10451	20
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	22/1485	45/6030	0.000349413686875721	0.0051656563978654	0.00424465559874632	2180/2182/9023/1593/1718/1717/54898/60481/3992/9415/2222/2224/3157/3158/51478/3422/4047/6307/4597/6319/8435/6713	22
WP1604	Codeine and morphine metabolism	8/1485	10/6030	0.000367367934841978	0.00528816474627795	0.00434532155616412	5243/1244/1558/1565/1576/54575/54578/7364	8
WP702	Metapathway biotransformation Phase I and II	48/1485	125/6030	0.000391159941516812	0.00531466742306149	0.0043670989890258	50515/166012/9435/9469/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420/2052/2053/2326/2327/2328/2330/9514/79690/92292/2938/2939/2947/2949/9955/90161/8514/9027/339983/4837/6817/6799/6822/54575/54657/54578/79799/7364	48
WP117	GPCRs, other	19/1485	37/6030	0.000398357156024719	0.00531466742306149	0.0043670989890258	27202/1131/3577/3579/2833/1909/2149/29933/4935/11245/1880/53831/59340/3363/59352/53829/5737/1901/6752	19
WP1533	Vitamin B12 metabolism	19/1485	37/6030	0.000398357156024719	0.00531466742306149	0.0043670989890258	335/338/875/6347/8029/2155/3383/3458/3553/3569/3949/4791/6288/6289/5054/6648/6947/6948/7124	19
WP474	Endochondral ossification	26/1485	57/6030	0.000421864138865094	0.00536650427812108	0.00440969369144174	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP4808	Endochondral ossification with skeletal dysplasias	26/1485	57/6030	0.000421864138865094	0.00536650427812108	0.00440969369144174	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	18/1485	35/6030	0.00055181643198196	0.00686008155213936	0.00563697647024634	285/597/332/664/1906/3091/3485/3486/3939/4843/5315/5366/5743/5054/6566/6513/6515/7043	18
WP3945	TYROBP causal network in microglia	27/1485	61/6030	0.000593610775040443	0.00721566875438049	0.00592916493432209	54518/718/8832/64764/79690/202309/3059/3142/10261/3587/3606/3684/3687/3689/4688/3071/375387/5341/170954/5996/864/64092/6696/6776/10312/113277/7133	27
WP4754	IL-18 signaling pathway	81/1485	239/6030	0.000649032196300543	0.007523978378741	0.00618250508558146	35/11096/321/467/330/841/6362/6363/6347/6364/6348/6351/890/9308/1051/1071/9076/24146/6900/1277/1278/1281/2920/2921/1674/1891/2023/338442/3315/26353/3383/8870/3458/3586/3606/8809/8807/3553/3559/3569/3659/3801/10365/4312/4322/4323/4313/4314/4318/653361/4688/4791/64332/4843/8431/3164/7941/5579/5743/5778/5806/6004/8698/9021/6696/341359/6869/30009/7052/7076/7078/55858/7124/7127/7128/4982/79931/7185/10194/80149/51222	81
WP24	Peptide GPCRs	20/1485	41/6030	0.000668348231607125	0.007523978378741	0.00618250508558146	185/728/1230/729230/1232/1233/1237/10803/3577/3579/2833/10663/1909/2357/2358/5540/6751/6752/6869/7253	20
WP272	Blood clotting cascade	10/1485	15/6030	0.000687749394766087	0.007523978378741	0.00618250508558146	2159/2160/2152/2155/3816/3818/5328/5054/5345/7450	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	10/1485	15/6030	0.000687749394766087	0.007523978378741	0.00618250508558146	302/335/338/1071/3949/3990/9388/4023/4547/255738	10
WP5109	Familial hyperlipidemia type 2	10/1485	15/6030	0.000687749394766087	0.007523978378741	0.00618250508558146	335/337/338/1071/2053/2690/3949/3990/4023/255738	10
WP3529	Zinc homeostasis	17/1485	33/6030	0.000765141092011057	0.00820651328098134	0.00674334873660932	4489/4493/4494/4495/4496/4500/4499/4501/4502/4504/55532/7780/7782/169026/29986/55630/283375	17
WP3929	Chemokine signaling pathway	55/1485	152/6030	0.000853417290067694	0.00897729341667363	0.00737670410645557	196883/10000/6356/6361/6363/6364/6367/6369/6370/10344/6348/6351/1230/729230/1232/1233/1237/10803/6376/3627/6373/2921/6374/4283/3579/2833/10663/1794/9844/2268/2784/59345/10681/51764/2786/2869/3055/3702/3717/3718/4067/653361/5196/5293/8503/23533/23236/5579/5880/25759/6772/6774/7409/10451/7454	55
WP5097	CCL18 signaling pathway	19/1485	39/6030	0.000925430831631644	0.00955114462080206	0.00784824161085823	467/1237/960/1278/1437/3091/3939/440823/4313/4318/6513/6615/6772/7004/7020/7291/7412/7424/7431	19
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	27/1485	63/6030	0.00108869562144749	0.0110280834246626	0.00906185244362729	59272/841/6347/6348/6351/11126/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3455/3586/3569/3902/5196/6772/7020/7124	27
WP2431	Spinal cord injury	38/1485	98/6030	0.00123648451141211	0.0122974005044077	0.0101048590693391	301/63827/6347/729230/983/50515/1280/1282/1464/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/1241/4321/4318/4843/3164/5320/5362/5743/6098/6403/57556/6869/7099/7124/10673/7431	38
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	18/1485	37/6030	0.0012825771513313	0.0125280303888968	0.0102943692409486	9744/9447/84674/834/838/841/50506/3606/3553/4210/58484/22861/91662/114548/199713/64127/639/8767	18
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	47/1485	128/6030	0.00139079440531028	0.0133467463106092	0.010967113777793	116/8553/720/721/1051/1103/1139/1141/1390/1644/54738/2328/2305/2697/2784/3091/7184/3359/3586/3552/3553/3557/3569/3764/4128/4760/4791/4821/4824/5354/5452/5460/10891/5577/864/6507/6532/6616/6750/6751/6752/6869/7068/7124/7161/7166/7433	47
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	13/1485	24/6030	0.00176994113778208	0.0166923759028758	0.0137162407592186	51/8309/246/240/66002/8529/10800/57105/1800/2358/1241/22949/8989	13
WP43	Oxidation by cytochrome P450	18/1485	38/6030	0.00188357527061743	0.0173074102942072	0.0142216187734561	51700/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420	18
WP4210	Tryptophan catabolism leading to NAD+ production	9/1485	14/6030	0.00189843622971194	0.0173074102942072	0.0142216187734561	23498/3620/8564/8942/10135/23057/349565/23475/6999	9
WP3892	Development of pulmonary dendritic cells and macrophage subsets	8/1485	12/6030	0.0024830418064037	0.022265965050866	0.0182960975208694	55509/1437/10320/3662/6688/6774/6925/7173	8
WP430	Statin inhibition of cholesterol production	13/1485	25/6030	0.00286490020571631	0.0252758131052713	0.0207693104896581	64240/64241/335/337/338/345/1071/2222/3949/3990/4023/4547/6713	13
WP5094	Orexin receptor pathway	41/1485	112/6030	0.00291480847378677	0.0253079402406566	0.0207957095790635	8553/2920/1734/1846/1959/1960/2324/84264/1839/3091/8091/9456/3309/3383/3586/3553/3569/3726/3777/3939/3949/4023/84230/23764/7873/4322/4314/4846/3164/8013/26031/5069/5163/6241/6401/6498/6513/6696/3371/7124/7412	41
WP197	Cholesterol biosynthesis pathway	9/1485	15/6030	0.00371446648213072	0.031747080714461	0.026086795853122	1717/2222/2224/3157/3422/4047/6307/4597/6713	9
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	27/1485	68/6030	0.00409280076160433	0.0344424925630395	0.0283016344162761	816/857/6347/958/1594/1673/2113/10964/3458/3569/9636/5600/6300/4791/64127/4939/23236/5333/5336/5579/91543/6258/6772/7097/7099/51311/7124	27
WP2880	Glucocorticoid receptor pathway	26/1485	65/6030	0.0042675567392524	0.0353689929753191	0.0290629462146854	51129/8553/330/6347/6364/1907/54566/9982/3589/4240/8972/4791/9970/5142/5460/5743/6286/6397/5272/1836/5552/2040/7056/7128/84951/1831	26
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	13/1485	26/6030	0.00445442478617679	0.0363667217617717	0.0298827868609189	51/8309/66002/8529/5729/5730/9536/5737/5739/5740/22949/5743/6916	13
WP15	Selenium micronutrient network	24/1485	59/6030	0.00460529807790672	0.0370455595384555	0.0304405925582998	240/335/338/875/6347/1734/1735/2155/3383/3458/3553/3569/8564/8942/3949/4791/10549/5743/6288/6289/5054/6648/7124/7498	24
WP5193	Cholesterol synthesis disorders	10/1485	18/6030	0.00476655532664796	0.0377870400532816	0.0310498722269821	1718/1717/2222/2224/3157/3422/4047/6307/4597/6713	10
WP4724	Omega-9 fatty acid synthesis	8/1485	13/6030	0.00506854107502138	0.0396070281148099	0.032545369008032	2180/2182/54898/60481/79071/3992/9415/6319	8
WP3942	PPAR signaling pathway	22/1485	54/6030	0.0063940796759526	0.049163767203108	0.0403982076315349	51/8309/2180/2182/51129/335/345/364/126129/1593/2168/2172/9415/3158/4023/4199/4312/4973/5105/6258/6319/28965	22
WP247	Small ligand GPCRs	9/1485	16/6030	0.0066510398044424	0.049163767203108	0.0403982076315349	4543/5724/5729/5737/5739/1901/9294/1903/8698	9
WP4478	LTF danger signal response pathway	9/1485	16/6030	0.0066510398044424	0.049163767203108	0.0403982076315349	177/3552/3553/3569/4057/7097/7099/7124/54210	9
WP516	Hypertrophy model	9/1485	16/6030	0.0066510398044424	0.049163767203108	0.0403982076315349	467/11072/1839/3458/3606/3552/3554/8013/6935	9
WP229	Irinotecan pathway	7/1485	11/6030	0.00686946901618638	0.0501013273580527	0.0411686072970047	4363/1244/9429/590/8824/1576/54575	7
WP465	Tryptophan metabolism	15/1485	33/6030	0.00714388392291347	0.0510876459176947	0.0419790720809307	8854/316/1545/1573/1576/66002/9420/1644/1718/23498/3620/8942/4129/6999/7166	15
WP4329	miRNAs involvement in the immune response in sepsis	17/1485	39/6030	0.0071914967745201	0.0510876459176947	0.0419790720809307	6348/6351/3002/3383/3586/3552/3569/3659/3934/114614/407008/407024/4791/7099/51311/7124/7412	17
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	11/1485	22/6030	0.00874862704375277	0.0613525511914457	0.0504138157581975	2919/2920/2247/3553/4821/5155/5354/6469/6663/55553/7124	11
WP697	Estrogen metabolism	8/1485	14/6030	0.00929534753543393	0.0638960109508728	0.0525037942384733	1545/1576/2938/1728/412/6817/54578/7364	8
WP5092	Interactions of natural killer cells in pancreatic cancer	12/1485	25/6030	0.00934493761621539	0.0638960109508728	0.0525037942384733	6347/6348/6351/10666/1437/2214/3002/3458/4277/5551/201633/7124	12
WP2848	Pluripotent stem cell differentiation pathway	15/1485	34/6030	0.0099283644026444	0.0670471028178579	0.0550930682252003	3577/22943/2246/2255/2247/3082/3589/3569/3624/5155/6469/7043/7173/7472/7474	15
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	9/1485	17/6030	0.0110827557128728	0.0739300899383102	0.0607488663593928	249/1594/5167/56975/2261/4791/6098/142680/6696	9
WP167	Eicosanoid synthesis	10/1485	20/6030	0.0123145757704845	0.080191344600655	0.0658937826315399	246/240/1800/5320/80339/5730/9536/5740/5743/6916	10
WP5044	Kynurenine pathway and links to cell senescence	10/1485	20/6030	0.0123145757704845	0.080191344600655	0.0658937826315399	23498/3620/169355/3458/8564/8942/23475/6999/7099/7124	10
WP98	Prostaglandin synthesis and regulation	17/1485	41/6030	0.0128452256709576	0.0818014426333968	0.0672168113238919	301/302/306/307/308/1906/1909/3290/10891/5729/5730/9536/5737/5739/5740/5743/6916	17
WP4495	IL-10 anti-inflammatory signaling pathway 	7/1485	12/6030	0.0130104671098821	0.0818014426333968	0.0672168113238919	644/3586/3587/3552/3569/6772/6774	7
WP5110	Familial hyperlipidemia type 3	7/1485	12/6030	0.0130104671098821	0.0818014426333968	0.0672168113238919	335/337/1071/3949/3990/4023/7436	7
WP4545	Oxysterols derived from cholesterol	14/1485	32/6030	0.013679781154275	0.0842535162570053	0.0692316971841456	134526/23597/8309/23600/9023/1593/1576/9420/1717/2053/1880/3605/3638/6097	14
WP2876	Pregnane X receptor pathway	13/1485	29/6030	0.0137085245829497	0.0842535162570053	0.0692316971841456	5243/1244/1557/1559/1576/1551/66002/2939/10891/27286/6822/54657/54578	13
WP5174	Ulcerative colitis signaling	8/1485	15/6030	0.0156734973106376	0.095260033654653	0.0782758286741785	50943/3108/3458/3586/4772/64127/7097/7124	8
WP306	Focal adhesion	58/1485	183/6030	0.0169092224397402	0.101641150269647	0.0835192363420365	10000/330/857/1101/1277/1278/1280/1282/1284/1286/1290/50509/1292/2268/2316/2318/2321/2534/3055/3082/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3791/284217/3909/3910/3911/3913/3915/3918/10319/29780/64098/5155/5159/5228/5293/8503/5579/5880/25759/6696/10420/7058/3371/7409/10451/7424/7450/7791	58
WP497	Urea cycle and metabolism of amino groups	9/1485	18/6030	0.0173989560990977	0.103176839791473	0.0847811230462022	445/1152/2628/162417/4942/4953/5009/5831/6723	9
WP2884	NRF2 pathway	39/1485	116/6030	0.0175419489956252	0.103176839791473	0.0847811230462022	1244/177/874/8824/23491/1969/2938/2939/2947/2949/1839/3082/23764/4199/1728/3084/5155/9588/22949/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/7042/54657/54578/7364	39
WP2875	Constitutive androstane receptor pathway	12/1485	27/6030	0.019020119303936	0.109515844834242	0.0899899273438304	5243/1244/1557/1559/1576/2939/9970/10891/6817/6822/54657/54578	12
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	12/1485	27/6030	0.019020119303936	0.109515844834242	0.0899899273438304	59272/6347/2939/2977/3553/3569/4312/4314/1728/5593/23657/7124	12
WP2289	Drug induction of bile acid pathway	7/1485	13/6030	0.0222760474838863	0.124336714017202	0.10216833808399	5243/1244/1576/9971/9970/123264/6822	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	7/1485	13/6030	0.0222760474838863	0.124336714017202	0.10216833808399	51/2180/2182/54898/60481/3992/9415	7
WP5108	Familial  hyperlipidemia type 1	7/1485	13/6030	0.0222760474838863	0.124336714017202	0.10216833808399	51129/335/337/1071/3949/3990/4023	7
WP716	Vitamin A and carotenoid metabolism	14/1485	34/6030	0.0244928441491745	0.135329148985843	0.111200897944684	64240/64241/8854/1381/1382/56603/4023/9227/29881/5915/5948/6258/195814/6817	14
WP4541	Hippo-Merlin signaling dysregulation	34/1485	101/6030	0.0249208332382258	0.136316957813095	0.112012587291815	84962/960/1009/1014/1001/1003/1004/3627/1969/2261/2321/2324/2305/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/3791/26524/5159/5577/6788/7004/7010	34
WP3613	Photodynamic therapy-induced unfolded protein response	11/1485	25/6030	0.0264223922843964	0.143099490886781	0.117585841640826	440/467/811/51726/4189/9695/121506/7184/3309/57761/7494	11
WP5098	T-cell activation SARS-CoV-2	28/1485	81/6030	0.0279822085555646	0.150061451763665	0.123306533057029	84433/6363/940/915/941/942/1029/1493/2534/3122/3123/29851/3455/3458/3594/3595/3605/8809/51561/3717/3937/4049/4772/5293/10125/6775/7124/7535	28
WP2858	Ectoderm differentiation	39/1485	120/6030	0.0303426459554137	0.161140071238945	0.132409911323063	398/170302/91653/6347/1004/5010/1496/1896/54898/2274/2534/2627/57476/9687/152789/3801/3853/9079/4061/4772/22871/5080/345557/5362/5420/5452/5783/114822/6386/5269/6469/6498/7903/6781/7020/4982/54521/7704/51222	39
WP4583	Biomarkers for urea cycle disorders	6/1485	11/6030	0.031861130629408	0.16490107097502	0.135500350825235	445/2159/2155/2628/162417/5009	6
WP4707	Aspirin and miRNAs	6/1485	11/6030	0.031861130629408	0.16490107097502	0.135500350825235	283120/114614/4597/4846/5163/5743	6
WP176	Folate metabolism	18/1485	48/6030	0.0319552349604243	0.16490107097502	0.135500350825235	335/338/875/6347/2155/3383/3458/3553/3569/3949/10797/4791/6288/6289/5054/113235/6648/7124	18
WP2879	Farnesoid X receptor pathway	7/1485	14/6030	0.0352567474323388	0.175023714823379	0.143818197305076	1576/2289/117283/8431/9971/10891/6822	7
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	7/1485	14/6030	0.0352567474323388	0.175023714823379	0.143818197305076	3589/3569/3572/3717/3718/6774/6935	7
WP4582	Cancer immunotherapy by CTLA4 blockade	7/1485	14/6030	0.0352567474323388	0.175023714823379	0.143818197305076	940/941/942/1493/3123/5293/8503	7
WP5130	Th17 cell differentiation pathway	22/1485	62/6030	0.0360055812680544	0.175023714823379	0.143818197305076	915/50943/3091/3108/3458/3605/3553/50615/51561/9466/3559/3569/3662/3717/4772/6097/9021/6772/6774/6776/30009/7535	22
WP3893	Development and heterogeneity of the ILC family	10/1485	23/6030	0.0367561627179816	0.175023714823379	0.143818197305076	3458/3605/3606/3553/51561/90865/3569/30009/7124/7704	10
WP4197	Immune response to tuberculosis	10/1485	23/6030	0.0367561627179816	0.175023714823379	0.143818197305076	3437/8519/3455/3659/10379/3717/5696/8651/6772/6890	10
WP4585	Cancer immunotherapy by PD-1 blockade	10/1485	23/6030	0.0367561627179816	0.175023714823379	0.143818197305076	10538/29126/915/3123/3458/4772/5133/80380/6774/7535	10
WP3287	Overview of nanoparticle effects	8/1485	17/6030	0.0367965762425751	0.175023714823379	0.143818197305076	10000/1001/1282/3569/3909/5293/5743/7124	8
WP3967	miR-509-3p alteration of YAP1/ECM axis	8/1485	17/6030	0.0367965762425751	0.175023714823379	0.143818197305076	1277/1281/1289/1909/6678/7004/7058/7291	8
WP5087	Malignant pleural mesothelioma	109/1485	381/6030	0.0372233303986876	0.17552725627657	0.144231960800722	72/9510/177/84962/10000/285/467/672/834/6347/6351/898/29126/960/1009/1014/1001/1003/1004/1029/1282/1284/1286/1437/1440/115908/1496/2919/3627/6374/80319/22943/1942/1946/1969/2246/2255/2259/2247/2252/2254/2261/2321/2324/8061/2305/11211/1839/3082/3091/3620/3586/3553/3569/3672/3673/3655/3685/3689/3690/3791/9493/284217/3909/3910/3911/3913/3915/3918/10319/26524/51176/9064/11184/9448/4323/4313/4314/4318/114548/5155/5159/5163/5228/5293/5328/5420/10891/9770/83593/6401/5176/6423/6425/6513/8140/64321/6678/6772/6788/7004/7010/7015/29128/7424/7480/7481/7472/7474	109
WP534	Glycolysis and gluconeogenesis	15/1485	39/6030	0.0383417349594083	0.179255803613644	0.147295733942126	229/230/2023/2026/2203/3099/3101/3939/5105/5214/5313/5315/6513/6514/6515	15
WP5083	Neuroinflammation and glutamatergic signaling	37/1485	115/6030	0.0396918732884738	0.183995378718603	0.151190275594811	816/27185/2247/2892/2893/2898/2906/116443/3458/3586/3587/3552/3553/3554/3569/3572/84230/80131/4049/4791/26227/23236/5579/29968/6505/6507/6509/6513/6515/92745/9021/6772/6774/7042/7043/7124/7133	37
WP75	Toll-like receptor signaling pathway	28/1485	84/6030	0.0443288187849547	0.203763561977901	0.1674339285376	10000/841/6348/6351/958/941/942/3627/6373/4283/3455/3553/3569/23643/1326/5600/6300/5293/8503/23533/6696/6772/7096/7097/7099/51311/54106/7124	28
WP5122	Prostaglandin and leukotriene metabolism in senescence 	11/1485	27/6030	0.0474573682870458	0.216326503775117	0.177756984724286	246/240/10800/3488/5600/23236/5730/9536/5740/5743/6916	11
WP2881	Estrogen receptor pathway	6/1485	12/6030	0.0507117941489338	0.225523182109486	0.185313958935342	51/1545/8431/5105/5166/6774	6
WP5112	Familial hyperlipidemia type 5	6/1485	12/6030	0.0507117941489338	0.225523182109486	0.185313958935342	335/337/1071/3949/3990/4023	6
WP5188	Retinol metabolism	6/1485	12/6030	0.0507117941489338	0.225523182109486	0.185313958935342	316/54905/1551/10170/9227/195814	6
WP727	Monoamine transport	9/1485	21/6030	0.0512101037786282	0.225902635217013	0.185625758178899	183/273/3553/3554/3690/6532/6999/7124/4982	9
WP2855	Dopaminergic neurogenesis	7/1485	15/6030	0.0523920912888272	0.229267791479908	0.188390930360667	1644/4009/4760/4821/4929/6469/6774	7
WP2406	Cardiac progenitor differentiation	12/1485	31/6030	0.0577987042321035	0.250919771547307	0.206182512173001	290/22943/2247/3624/3670/3791/83881/3084/5080/5460/64321/7070	12
WP236	Adipogenesis	36/1485	115/6030	0.060977366940044	0.262634800914993	0.215808832850384	183/651/1051/1675/1271/56603/1879/1959/2487/3091/3569/3572/8609/23175/4023/83881/10135/7025/5008/5105/80339/10891/5618/5740/6258/6319/5054/8651/9021/6772/6774/6776/7124/57761/7291/7480	36
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	18/1485	52/6030	0.0681782326990929	0.287542818685223	0.236275923368788	308/602/332/79092/2113/2149/3309/3315/8870/3575/1728/3084/8767/9021/7124/7185/10451/7431	18
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	18/1485	52/6030	0.0681782326990929	0.287542818685223	0.236275923368788	10000/898/1003/1277/1278/2321/3082/3791/4313/4318/4791/5361/5362/91584/55630/6615/7042/7043	18
WP3591	Sleep regulation	9/1485	22/6030	0.0683374157752816	0.287542818685223	0.236275923368788	100/134/1141/51738/3606/3569/22871/5729/5730	9
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5/1485	10/6030	0.0736776455154126	0.306376070678588	0.251751336822394	1116/3572/4318/9021/6774	5
WP3413	NOTCH1 regulation of endothelial cell calcification	7/1485	16/6030	0.0739335307670451	0.306376070678588	0.251751336822394	249/813/2261/2702/3672/4256/55553	7
WP554	ACE inhibitor pathway	6/1485	13/6030	0.075085291290403	0.30880943109662	0.253750845912165	1636/59272/183/185/3827/4846	6
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	8/1485	20/6030	0.0943456175692134	0.385127259778804	0.316461733716057	332/3315/3569/3791/4318/6696/6774/7099	8
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	21/1485	65/6030	0.099047671372963	0.401326490674154	0.329772753810957	947/22943/147409/1959/94234/2619/3458/3488/26085/5653/5650/51176/4488/4772/22822/864/25928/6925/8626/7474/7704	21
WP5111	Familial hyperlipidemia type 4	7/1485	17/6030	0.0999293989341741	0.401921920713186	0.330262022793285	335/337/1071/3949/3990/4023/4547	7
WP2197	Endothelin pathways	10/1485	27/6030	0.103956483225812	0.415067126456343	0.341063529292521	10203/1906/1909/2769/10681/51764/4846/4852/23236/5739	10
WP12	Osteoclast signaling	6/1485	14/6030	0.104956699183951	0.416024017779865	0.341849813512946	1513/8111/3690/5155/6696/4982	6
WP4008	NO/cGMP/PKG mediated neuroprotection	12/1485	34/6030	0.108510315901831	0.424021667612865	0.348421537709407	816/1259/1261/2906/2977/3458/3553/4843/4846/4881/5593/7124	12
WP5052	Nephrogenesis	5/1485	11/6030	0.10852474125375	0.424021667612865	0.348421537709407	8854/80000/130497/284654/84870	5
WP3646	Hepatitis C and hepatocellular carcinoma	16/1485	48/6030	0.110090675505606	0.427089358167139	0.350942280260499	330/332/672/960/1284/3577/2487/3091/3569/51176/4312/4843/5420/5743/6241/6774	16
WP1539	Angiogenesis	9/1485	24/6030	0.112120663402491	0.431901428740582	0.354896391941169	2247/2321/3091/3791/4318/4846/5155/7010/7078	9
WP3925	Amino acid metabolism	24/1485	77/6030	0.115111836194495	0.44032289789083	0.361816371402645	126/440/445/586/875/1644/84706/3034/3067/3158/3939/4128/4357/4942/4953/5009/5105/5166/5315/5831/6723/6999/7166/7173	24
WP4496	Signal transduction through IL1R	11/1485	31/6030	0.117614530542245	0.446771862545888	0.367115530274404	3552/3553/3554/3556/3557/3569/3656/11213/7042/7043/7124	11
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	8/1485	21/6030	0.12089054913265	0.45604917500386	0.374738762102662	941/942/3101/3122/3586/3939/5210/6515	8
WP4136	Fibrin complement receptor 3 signaling pathway	12/1485	35/6030	0.129829637697314	0.484596154266888	0.398196012454462	6347/3627/2921/3569/3656/3684/3689/23643/4843/83593/7099/7124	12
WP3877	MYD88 distinct input-output pathway	7/1485	18/6030	0.130229679483058	0.484596154266888	0.398196012454462	3552/92610/7096/7097/7099/51311/54106	7
WP4900	Purinergic signaling	9/1485	25/6030	0.138686345530569	0.509173726668412	0.41839157372734	134/5027/27334/53829/9934/5030/5031/286530/24145	9
WP4747	Netrin-UNC5B signaling pathway	15/1485	46/6030	0.138696316770738	0.509173726668412	0.41839157372734	249/6347/1003/1277/2534/3383/3586/3552/3635/3791/59277/54538/6401/7124/7412	15
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5/1485	12/6030	0.149819703471476	0.546342518659314	0.448933427244351	2222/2224/3157/3422/4597	5
WP4595	Urea cycle and associated pathways	8/1485	22/6030	0.150920911051146	0.546713498973358	0.449238264334887	8659/445/162417/4843/4846/4942/5009/5831	8
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	20/1485	65/6030	0.155925854764558	0.561127911554035	0.461082686873035	816/941/9076/1286/1378/1514/22943/1759/2534/3685/3690/3911/3913/4288/4311/4868/5329/5420/7099/7431	20
WP286	IL-3 signaling pathway	15/1485	47/6030	0.15967610915865	0.569287787252746	0.467787713185649	1232/969/942/1439/2534/3055/3563/3568/3635/3717/4067/5293/6774/6776/7409	15
WP4746	Thyroid hormones production and peripheral downstream signaling effects	24/1485	80/6030	0.160274806648854	0.569287787252746	0.467787713185649	10000/364/1734/1735/50506/405753/3685/3690/389434/152831/57224/4881/4852/23236/10891/5593/27330/6469/6567/5172/7038/7068/7173/7253	24
WP299	Nuclear receptors in lipid metabolism and toxicity	9/1485	26/6030	0.168151001052453	0.585850939972558	0.481397770361363	5243/1244/64240/1594/1559/1576/9971/9970/5915	9
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	9/1485	26/6030	0.168151001052453	0.585850939972558	0.481397770361363	2254/2261/3549/5600/6300/5745/5744/6615/6772	9
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	9/1485	26/6030	0.168151001052453	0.585850939972558	0.481397770361363	1390/2555/2557/2562/2564/2568/3717/8503/6774	9
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	6/1485	16/6030	0.179639515322227	0.619183301506745	0.508787202431214	2534/3122/3123/3569/64386/7535	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	38/1485	134/6030	0.179981983436147	0.619183301506745	0.508787202431214	10000/8999/9076/5010/24146/51208/9075/137075/9073/1282/1284/1286/56648/2305/94234/11211/3091/3678/26524/5600/6300/4313/4318/4854/4855/8828/5293/8503/6615/6678/7042/7043/7291/7480/7481/7472/7474/6935	38
WP2361	Gastric cancer network 1	8/1485	23/6030	0.184137583673867	0.625610299811212	0.514068311400727	6790/144455/1894/11082/4605/6286/22974/11065	8
WP5064	7-oxo-C and 7-beta-HC pathways	8/1485	23/6030	0.184137583673867	0.625610299811212	0.514068311400727	134526/23597/8309/23600/1593/1717/2053/3290	8
WP1434	Osteopontin signaling	5/1485	13/6030	0.196528711084646	0.655495152215251	0.53862490136806	3685/3690/4318/5328/6696	5
WP5176	Disorders of bile acid synthesis and biliary transport	5/1485	13/6030	0.196528711084646	0.655495152215251	0.53862490136806	1244/8309/23600/1593/9420	5
WP5178	Disorders of fructose metabolism	5/1485	13/6030	0.196528711084646	0.655495152215251	0.53862490136806	229/2203/3795/6514/6652	5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	14/1485	45/6030	0.198067027094629	0.656622204974316	0.539551008417267	695/6356/2534/3055/3559/3569/3575/3717/4067/4791/6772/6774/6775/6776	14
WP5222	2q13 copy number variation syndrome	15/1485	49/6030	0.206215229770634	0.677821543750737	0.556970651749379	55289/150468/1437/3552/3553/3554/3556/3557/51561/3569/284958/5336/8651/9021/6772	15
WP4298	Acute viral myocarditis	23/1485	79/6030	0.209492227015221	0.677821543750737	0.556970651749379	834/841/857/1232/1604/941/1906/2534/3108/3458/3586/3569/3683/3689/4318/4791/64127/5880/8651/6772/6774/7099/7124	23
WP2374	Oncostatin M signaling pathway	19/1485	64/6030	0.209646460339577	0.677821543750737	0.556970651749379	6347/1051/3091/3572/3717/3718/3726/3949/4312/4322/4314/5008/9180/5579/5054/9021/6772/6774/7078	19
WP4018	Clear cell renal cell carcinoma pathways	24/1485	83/6030	0.213879579499122	0.677821543750737	0.556970651749379	229/230/2023/2026/2321/3091/3099/3101/3791/8844/3939/4199/5155/5159/5214/26227/5313/5315/29968/6513/6774/7042/7043/6935	24
WP2064	Neural crest differentiation	20/1485	68/6030	0.215152637104773	0.677821543750737	0.556970651749379	1004/1302/1280/2113/2247/2261/51564/23493/3670/4359/4488/4791/4854/4855/283659/6615/6663/6925/7020/7291	20
WP1423	Ganglio sphingolipid metabolism	4/1485	10/6030	0.21532485439103	0.677821543750737	0.556970651749379	6482/6483/8869/6489	4
WP2436	Dopamine metabolism	4/1485	10/6030	0.21532485439103	0.677821543750737	0.556970651749379	1644/4128/4129/1728	4
WP4389	Bile acids synthesis and enterohepatic circulation 	4/1485	10/6030	0.21532485439103	0.677821543750737	0.556970651749379	64240/64241/3949/6555	4
WP364	IL6 signaling pathway	13/1485	42/6030	0.215614165653799	0.677821543750737	0.556970651749379	183/3055/3569/3572/3659/3717/3726/639/9021/6772/6774/7076/7409	13
WP5036	Angiotensin II receptor type 1 pathway	8/1485	24/6030	0.220146043809554	0.688113634079006	0.565427733574013	59272/183/185/1277/1278/3091/3589/3572	8
WP2324	AGE/RAGE pathway	19/1485	65/6030	0.231835406120563	0.720533904249705	0.592067693860529	177/249/841/3091/3625/3717/4322/4323/4313/4316/4318/4478/653361/4843/4846/5579/6772/6774/6776	19
WP4561	Cell migration and invasion through p75NTR	9/1485	28/6030	0.234645235685951	0.725146575820424	0.595857958001195	11093/10000/1009/1942/1946/4313/4318/6774/7291	9
WP4823	Genes controlling nephrogenesis	10/1485	32/6030	0.246683650373525	0.743565505017162	0.610992919546479	2118/2296/6928/8516/3791/3913/4868/5155/5159/6469	10
WP1602	Nicotine effect on dopaminergic neurons	5/1485	14/6030	0.247402051029476	0.743565505017162	0.610992919546479	1136/1141/1644/3777/84152	5
WP3935	Leptin-insulin signaling overlap	5/1485	14/6030	0.247402051029476	0.743565505017162	0.610992919546479	3717/8503/8651/9021/6774	5
WP3971	OSX and miRNAs in tooth development	5/1485	14/6030	0.247402051029476	0.743565505017162	0.610992919546479	249/22943/407024/4854/4855	5
WP58	Monoamine GPCRs	5/1485	14/6030	0.247402051029476	0.743565505017162	0.610992919546479	147/150/1131/3274/3363	5
WP2873	Aryl hydrocarbon receptor pathway	11/1485	36/6030	0.256860035361043	0.763600213817883	0.627455578370511	23491/1545/2939/3458/3553/3726/1728/8140/7124/54657/54578	11
WP4564	Neural crest cell migration during development	11/1485	36/6030	0.256860035361043	0.763600213817883	0.627455578370511	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP4658	Small cell lung cancer	26/1485	93/6030	0.260533834793514	0.770335176389471	0.632989743708851	10000/330/841/898/1030/1282/1284/1286/3673/3655/3685/284217/3909/3910/3911/3913/3915/3918/10319/4843/5293/8503/5743/5915/6258/7185	26
WP4760	PKC-gamma calcium signaling pathway in ataxia	6/1485	18/6030	0.269561801195673	0.783240203558567	0.643593893812197	773/2769/2892/2893/5163/23236	6
WP5149	Lipid metabolism in senescent cells	6/1485	18/6030	0.269561801195673	0.783240203558567	0.643593893812197	240/84647/50487/283748/7941/5743	6
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	17/1485	59/6030	0.269582746648266	0.783240203558567	0.643593893812197	84433/940/915/1437/1493/2534/29851/3458/3586/3702/3937/1326/5133/5163/5788/7124/7535	17
WP69	T-cell receptor signaling pathway	24/1485	86/6030	0.274778529831078	0.783240203558567	0.643593893812197	84433/940/915/9308/2534/29851/3601/3605/3552/3553/3569/3662/3702/3937/1326/11184/4772/8767/3604/7409/10451/7431/7454/7535	24
WP3930	EDA signaling in hair follicle development	4/1485	11/6030	0.276353490469476	0.783240203558567	0.643593893812197	22943/1896/6469/25928	4
WP4629	Aerobic glycolysis	4/1485	11/6030	0.276353490469476	0.783240203558567	0.643593893812197	2023/3939/5315/6513	4
WP5049	Glycolysis in senescence	4/1485	11/6030	0.276353490469476	0.783240203558567	0.643593893812197	230/2023/3939/5315	4
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	4/1485	11/6030	0.276353490469476	0.783240203558567	0.643593893812197	2358/1241/5163/5293	4
WP2118	Arrhythmogenic right ventricular cardiomyopathy	17/1485	60/6030	0.295641200489563	0.827655504874356	0.680090254173675	775/9254/785/1496/1674/2697/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/51176	17
WP241	One-carbon metabolism	8/1485	26/6030	0.298626249878165	0.827655504874356	0.680090254173675	10840/275/55349/2346/2745/25902/10797/6948	8
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5/1485	15/6030	0.301103190987197	0.827655504874356	0.680090254173675	23086/84958/94120/94122/201294	5
WP4159	GABA receptor signaling	5/1485	15/6030	0.301103190987197	0.827655504874356	0.680090254173675	2555/2557/2562/2564/2568	5
WP4842	Mammalian disorder of sexual development	5/1485	15/6030	0.301103190987197	0.827655504874356	0.680090254173675	84733/2254/5600/5730/284654	5
WP698	Glucuronidation	5/1485	15/6030	0.301103190987197	0.827655504874356	0.680090254173675	54575/54657/54578/79799/7364	5
WP2839	Hair follicle development: organogenesis - part 2 of 3	9/1485	30/6030	0.308771576670155	0.840288818102361	0.690471135051878	1896/2246/3624/3911/51176/6469/6615/8626/7474	9
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	9/1485	30/6030	0.308771576670155	0.840288818102361	0.690471135051878	59272/3455/10379/4939/4940/6772/7097/7099/54106	9
WP5053	Development of ureteric collection system	15/1485	53/6030	0.314170462519674	0.84571722633292	0.694931695649296	653/2118/2296/80144/2719/80000/6928/8516/4613/5915/6091/6469/7042/57216/7481	15
WP1591	Heart development	10/1485	34/6030	0.317092932462339	0.84571722633292	0.694931695649296	8553/2255/2296/2627/23493/3670/4772/5308/6469/7424	10
WP3599	Transcription factor regulation in adipogenesis	6/1485	19/6030	0.318048866121459	0.84571722633292	0.694931695649296	1051/3569/23175/10891/7124/7291	6
WP5066	FOXA2 pathway	6/1485	19/6030	0.318048866121459	0.84571722633292	0.694931695649296	1244/338/2938/2939/51085/4547	6
WP289	Myometrial relaxation and contraction pathways	35/1485	131/6030	0.318496798216785	0.84571722633292	0.694931695649296	196883/133/467/800/816/1265/2697/2784/59345/10681/51764/2786/2869/2980/2981/3485/3486/3488/3553/3569/23764/4846/5142/5333/5336/5577/5579/10266/10268/5996/6004/64407/10287/5999/8490	35
WP4917	Proximal tubule transport	12/1485	42/6030	0.32996352394271	0.864955935156337	0.710740275785156	5243/1244/9429/6560/6505/6513/6514/142680/6519/8671/340024/11136	12
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	7/1485	23/6030	0.330485905754432	0.864955935156337	0.710740275785156	185/285/2022/2200/2316/4053/5054	7
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	7/1485	23/6030	0.330485905754432	0.864955935156337	0.710740275785156	1636/59272/183/3606/3569/114548/7124	7
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/1485	12/6030	0.339620383968477	0.876284669956399	0.72004917554389	8061/6776/7076/7431	4
WP4792	Purine metabolism	4/1485	12/6030	0.339620383968477	0.876284669956399	0.72004917554389	100/3614/4860/7498	4
WP5171	Leukotriene metabolic pathway	4/1485	12/6030	0.339620383968477	0.876284669956399	0.72004917554389	4363/240/1800/22949	4
WP4816	TGF-beta receptor signaling in skeletal dysplasias	15/1485	54/6030	0.34334942205703	0.881747107348334	0.724537698138629	81794/25805/2022/2200/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	15
WP4241	Type 2 papillary renal cell carcinoma	9/1485	31/6030	0.347650160195025	0.888619801993826	0.730185038874942	253559/81578/1513/112399/3091/5155/6513/7042/7043	9
WP4558	Overview of interferons-mediated signaling pathway	5/1485	16/6030	0.356313952653093	0.906528986517404	0.744901139695817	3455/3458/10379/3717/6772	5
WP4565	Neural crest cell migration in cancer	11/1485	39/6030	0.358994199606618	0.909119570300093	0.747029840312017	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP26	S1P receptor signal transduction	7/1485	24/6030	0.375919966555265	0.943248723420779	0.775074001540792	10000/6300/23236/1901/9294/1903/8877	7
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	7/1485	24/6030	0.375919966555265	0.943248723420779	0.775074001540792	196883/2769/4935/23236/5579/5176/7306	7
WP2583	T cell receptor and co-stimulatory signaling	8/1485	28/6030	0.382209891713934	0.95031277621601	0.780878582592584	940/1493/2534/3702/5133/5163/10125/7535	8
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	8/1485	28/6030	0.382209891713934	0.95031277621601	0.780878582592584	9509/1277/1278/60681/4015/5034/5176/4982	8
WP3995	Prion disease pathway	9/1485	32/6030	0.387158794473004	0.953945317913212	0.783863467235527	10538/1879/2534/7184/3309/3662/5452/6688/6774	9
WP3998	Prader-Willi and Angelman syndrome	9/1485	32/6030	0.387158794473004	0.953945317913212	0.783863467235527	57194/990/1029/1030/9638/2562/51738/4948/5122	9
WP2267	Synaptic vesicle pathway	12/1485	44/6030	0.397153406998068	0.974183469183602	0.800493296144325	773/10814/1759/26052/22999/246213/6570/6507/6532/6616/2054/6857	12
WP395	IL-4 signaling pathway	14/1485	52/6030	0.401413167457095	0.97592710449687	0.801926053343912	332/1051/9046/2316/3635/3717/3718/5600/5293/8651/9021/6772/6774/6776	14
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4/1485	13/6030	0.403216683027957	0.97592710449687	0.801926053343912	249/3655/7015/7124	4
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	4/1485	13/6030	0.403216683027957	0.97592710449687	0.801926053343912	56624/3091/1901/1903	4
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5/1485	17/6030	0.411812365998215	0.987988439478173	0.811836935739786	9595/51176/3371/7412/7472	5
WP5074	Kallmann syndrome	5/1485	17/6030	0.411812365998215	0.987988439478173	0.811836935739786	23129/60675/9723/6663/26022	5
WP383	Striated muscle contraction pathway	6/1485	21/6030	0.417533329379147	0.993512165830877	0.816375819897593	1674/7134/7125/7169/7171/7431	6
WP205	IL-7 signaling pathway	7/1485	25/6030	0.421591057088325	0.993512165830877	0.816375819897593	2534/3559/3575/3718/6772/6774/6776	7
WP4950	16p11.2 distal deletion syndrome	7/1485	25/6030	0.421591057088325	0.993512165830877	0.816375819897593	718/3732/8519/3717/3791/5350/7185	7
WP581	EPO receptor signaling	7/1485	25/6030	0.421591057088325	0.993512165830877	0.816375819897593	3717/5163/5788/8651/6772/6774/6776	7
WP408	Oxidative stress response	8/1485	29/6030	0.424591324476133	0.993512165830877	0.816375819897593	1536/3726/4128/4501/1728/6648/54578/7498	8
WP4756	Renin-angiotensin-aldosterone system (RAAS)	9/1485	33/6030	0.4268738204161	0.993512165830877	0.816375819897593	1636/183/185/57118/816/64764/84699/9586/3283	9
WP4148	Splicing factor NOVA regulated synaptic proteins	10/1485	37/6030	0.428645102625387	0.993512165830877	0.816375819897593	288/23705/1600/1946/2036/2037/2898/3763/22854/2054	10
WP4331	Neovascularisation processes	10/1485	37/6030	0.428645102625387	0.993512165830877	0.816375819897593	2324/3091/3791/4318/4791/4854/4855/5155/7042/7043	10
WP3611	Photodynamic therapy-induced AP-1 survival signaling	13/1485	49/6030	0.432026816385906	0.994554162440527	0.817232035720399	602/890/898/1029/2252/1839/3458/3569/3726/5600/6300/4313/7124	13
WP585	Interferon type I signaling pathways	14/1485	53/6030	0.432731061537195	0.994554162440527	0.817232035720399	2534/3455/10379/27250/5293/5788/8651/9021/6772/6774/6775/6776/7409/7535	14
WP185	Integrin-mediated cell adhesion	24/1485	94/6030	0.458473269595882	0.99999999999996	0.821706918117932	10000/11131/827/857/2534/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/6300/5880/7145/10451/7791	24
WP3656	Interleukin-1 induced activation of NF-kB	3/1485	10/6030	0.463227951011979	0.99999999999996	0.821706918117932	84962/3552/92610	3
WP4846	SARS-CoV-2 and COVID-19 pathway	3/1485	10/6030	0.463227951011979	0.99999999999996	0.821706918117932	59272/1514/340024	3
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3/1485	10/6030	0.463227951011979	0.99999999999996	0.821706918117932	718/629/1675	3
WP560	TGF-beta receptor signaling	13/1485	50/6030	0.464546548210003	0.99999999999996	0.821706918117932	25805/2022/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	13
WP4584	Biomarkers for pyrimidine metabolism disorders	4/1485	14/6030	0.46554253582735	0.99999999999996	0.821706918117932	1152/51251/6241/1890	4
WP5061	Fatty acid transporters	4/1485	14/6030	0.46554253582735	0.99999999999996	0.821706918117932	2180/2182/2168/2172	4
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/1485	18/6030	0.4665241216915	0.99999999999996	0.821706918117932	308/1280/2252/3490/1728	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/1485	18/6030	0.4665241216915	0.99999999999996	0.821706918117932	1014/1004/6615/3371/7431	5
WP3927	BMP signaling in eyelid development	5/1485	18/6030	0.4665241216915	0.99999999999996	0.821706918117932	2255/2296/3625/5308/6469	5
WP4533	Transcription co-factors SKI and SKIL protein partners	5/1485	18/6030	0.4665241216915	0.99999999999996	0.821706918117932	26524/23314/6498/6788/7004	5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	6/1485	22/6030	0.466878910867175	0.99999999999996	0.821706918117932	1244/9429/2052/5600/6300/1728	6
WP4537	Hippo-Yap signaling pathway	6/1485	22/6030	0.466878910867175	0.99999999999996	0.821706918117932	3627/26524/11184/9448/6788/7004	6
WP4875	Disruption of postsynaptic signaling by CNV	7/1485	26/6030	0.46689388079733	0.99999999999996	0.821706918117932	816/1740/2906/9456/22871/57555/9378	7
WP4673	Male infertility	25/1485	100/6030	0.504155688092978	0.99999999999996	0.821706918117932	5243/27161/338/675/1191/56603/94240/2346/3122/4057/4313/4318/4843/4846/1728/55124/29968/9985/113235/6648/6948/7124/9319/10537/7516	25
WP34	Ovarian infertility	6/1485	23/6030	0.515017618554025	0.99999999999996	0.821706918117932	1051/2701/5618/23224/7783/7784	6
WP1584	Type II diabetes mellitus	5/1485	19/6030	0.5195509986808	0.99999999999996	0.821706918117932	773/3651/23533/6514/7124	5
WP2895	Differentiation of white and brown adipocyte	5/1485	19/6030	0.5195509986808	0.99999999999996	0.821706918117932	1051/253738/27129/51316/10891	5
WP325	Triacylglyceride synthesis	5/1485	19/6030	0.5195509986808	0.99999999999996	0.821706918117932	56895/2819/3990/4023/80168	5
WP5194	Synthesis of ceramides and 1-deoxyceramides	5/1485	19/6030	0.5195509986808	0.99999999999996	0.821706918117932	53947/2683/1674/259230/8877	5
WP1946	Cori cycle	4/1485	15/6030	0.525338661223769	0.99999999999996	0.821706918117932	3939/5214/6513/6514	4
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/1485	15/6030	0.525338661223769	0.99999999999996	0.821706918117932	1051/2939/1728/23657	4
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4/1485	15/6030	0.525338661223769	0.99999999999996	0.821706918117932	699/701/991/1062	4
WP5101	Congenital generalized lipodystrophy (CGL)	4/1485	15/6030	0.525338661223769	0.99999999999996	0.821706918117932	857/2534/3091/23175	4
WP3630	NAD metabolism, sirtuins and aging	3/1485	11/6030	0.533305873715417	0.99999999999996	0.821706918117932	3091/10135/6098	3
WP4271	Vitamin B12 disorders	3/1485	11/6030	0.533305873715417	0.99999999999996	0.821706918117932	8029/6947/6948	3
WP4963	p53 transcriptional gene network	20/1485	81/6030	0.53777918869298	0.99999999999996	0.821706918117932	8659/6790/6347/898/126129/6376/54541/55332/144455/3383/10379/9636/4688/5366/5371/5268/5054/6513/23657/7124	20
WP3940	One-carbon metabolism and related pathways	10/1485	40/6030	0.539056323026353	0.99999999999996	0.821706918117932	64902/586/587/23743/55349/56994/29958/1759/2882/6648	10
WP4222	Phosphodiesterases in neuronal function	10/1485	40/6030	0.539056323026353	0.99999999999996	0.821706918117932	196883/1139/2906/2977/10846/5153/5137/5142/5145/84152	10
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	9/1485	36/6030	0.543423070953024	0.99999999999996	0.821706918117932	684/3429/8519/10581/10410/3726/5600/6300/6196	9
WP3298	Melatonin metabolism and effects	8/1485	32/6030	0.548438906596695	0.99999999999996	0.821706918117932	1545/1557/1565/1906/4128/406938/4543/6817	8
WP4542	Leukocyte-intrinsic Hippo pathway functions	8/1485	32/6030	0.548438906596695	0.99999999999996	0.821706918117932	50943/3683/26524/4023/639/83593/6788/7004	8
WP4481	Resistin as a regulator of inflammation	7/1485	28/6030	0.554316359534445	0.99999999999996	0.821706918117932	10000/3569/5293/23236/5333/5336/7124	7
WP4655	Cytosolic DNA-sensing pathway	14/1485	57/6030	0.555834349248203	0.99999999999996	0.821706918117932	9447/834/843/841/6351/9560/3627/3606/3553/90865/3569/9636/10622/81030	14
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	12/1485	49/6030	0.564070615462569	0.99999999999996	0.821706918117932	27161/1051/1513/8091/3726/51176/4128/4129/6696/7042/4982/7480	12
WP2355	Corticotropin-releasing hormone signaling pathway	19/1485	78/6030	0.565941347547756	0.99999999999996	0.821706918117932	1393/8061/2697/2784/10681/3283/3606/3726/3861/4846/3164/4929/5336/5579/10411/6822/6925/7020/7099	19
WP3580	Methionine de novo and salvage pathway	5/1485	20/6030	0.570180742074932	0.99999999999996	0.821706918117932	51074/55349/259307/4953/6723	5
WP3640	Imatinib and chronic myeloid leukemia	5/1485	20/6030	0.570180742074932	0.99999999999996	0.821706918117932	5243/9429/2321/5159/11040	5
WP3645	NAD+ biosynthetic pathways	5/1485	20/6030	0.570180742074932	0.99999999999996	0.821706918117932	952/3620/10135/23475/6999	5
WP4224	Purine metabolism and related disorders	5/1485	20/6030	0.570180742074932	0.99999999999996	0.821706918117932	100/316/3614/4860/7498	5
WP2332	Interleukin-11 signaling pathway	10/1485	41/6030	0.5742233282473	0.99999999999996	0.821706918117932	332/2534/3383/3589/3572/3673/3717/9021/6772/6774	10
WP5220	Metabolic reprogramming in pancreatic cancer	10/1485	41/6030	0.5742233282473	0.99999999999996	0.821706918117932	587/3099/3158/3939/3949/4199/5315/6566/6513/8140	10
WP4217	Ebola virus infection in host	30/1485	124/6030	0.580010836452008	0.99999999999996	0.821706918117932	432/684/857/11314/93978/1514/2316/2318/3108/3112/3119/3122/3123/3134/3384/3672/3673/3678/3655/3685/3690/4240/4791/5293/8503/9021/6772/7020/91937/7099	30
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4/1485	16/6030	0.581680230747327	0.99999999999996	0.821706918117932	3157/3949/10891/6319	4
WP22	IL-9 signaling pathway	4/1485	16/6030	0.581680230747327	0.99999999999996	0.821706918117932	3718/6772/6774/6776	4
WP3644	NAD+ metabolism	4/1485	16/6030	0.581680230747327	0.99999999999996	0.821706918117932	952/10135/23057/349565	4
WP368	Mitochondrial long chain fatty acid beta-oxidation	4/1485	16/6030	0.581680230747327	0.99999999999996	0.821706918117932	35/80221/2180/2182	4
WP4225	Pyrimidine metabolism and related diseases	4/1485	16/6030	0.581680230747327	0.99999999999996	0.821706918117932	51251/5009/6241/1890	4
WP1601	Fluoropyrimidine activity	7/1485	29/6030	0.595592507052999	0.99999999999996	0.821706918117932	9429/8824/6241/7083/1890/7371/7378	7
WP4211	Transcriptional cascade regulating adipogenesis	3/1485	12/6030	0.597867703631064	0.99999999999996	0.821706918117932	1051/1959/10365	3
WP5223	2q21.1 copy number variation syndrome	3/1485	12/6030	0.597867703631064	0.99999999999996	0.821706918117932	205147/50649/6774	3
WP536	Calcium regulation in cardiac cells	30/1485	125/6030	0.599937028413581	0.99999999999996	0.821706918117932	196883/147/773/775/777/811/816/1131/2697/2701/2702/127534/2709/10052/2784/59345/10681/51764/2786/2869/3760/5350/5577/5579/5996/6004/64407/10287/5999/8490	30
WP1528	Physiological and pathological hypertrophy of the heart	6/1485	25/6030	0.605528485332125	0.99999999999996	0.821706918117932	183/1906/3572/5600/5579/6774	6
WP4630	Measles virus infection	28/1485	117/6030	0.605675833094178	0.99999999999996	0.821706918117932	841/898/940/915/3310/3455/3552/3553/3559/3560/3569/10379/3718/4478/4791/4939/4940/5293/8503/6504/6772/6774/6776/7097/7099/54106/7128/7161	28
WP304	Kit receptor signaling pathway	14/1485	59/6030	0.613771055102638	0.99999999999996	0.821706918117932	695/2534/3635/3717/3726/4067/5579/10603/6615/8651/6772/6774/6776/7409	14
WP5072	Modulators of TCR signaling and T cell activation	14/1485	59/6030	0.613771055102638	0.99999999999996	0.821706918117932	84433/940/915/921/3702/3937/1326/11184/399/4068/8651/7128/7409/7535	14
WP4758	Nephrotic syndrome	9/1485	38/6030	0.615793451888132	0.99999999999996	0.821706918117932	54443/8542/1286/1493/8029/2262/3913/4868/5420	9
WP262	Ebstein-Barr virus LMP1 signaling	5/1485	21/6030	0.617883058542365	0.99999999999996	0.821706918117932	6364/4791/9260/7124/7185	5
WP170	Nuclear receptors	8/1485	34/6030	0.624553516972956	0.99999999999996	0.821706918117932	9970/7025/3164/4929/5915/6097/6258/7068	8
WP3286	Copper homeostasis	12/1485	51/6030	0.625867362405833	0.99999999999996	0.821706918117932	8754/4489/4493/4494/4495/4496/4500/4501/4502/4504/79689/54739	12
WP3874	Canonical and non-canonical TGF-B signaling	4/1485	17/6030	0.633947266054746	0.99999999999996	0.821706918117932	26585/4015/4016/4017	4
WP4784	Proteoglycan biosynthesis	4/1485	17/6030	0.633947266054746	0.99999999999996	0.821706918117932	9469/22856/55790/1836	4
WP4912	SARS coronavirus and innate immunity	4/1485	17/6030	0.633947266054746	0.99999999999996	0.821706918117932	59272/3455/10379/6772	4
WP4149	White fat cell differentiation	7/1485	30/6030	0.634818349423953	0.99999999999996	0.821706918117932	1051/1879/1959/3662/10365/6776/7480	7
WP4787	Osteoblast differentiation and related diseases	23/1485	98/6030	0.64407556412342	0.99999999999996	0.821706918117932	2246/2255/2247/2252/2254/2261/11211/23493/3549/5600/6300/4854/4855/5288/5293/8503/23533/5579/6772/7480/7481/7472/7474	23
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	3/1485	13/6030	0.656263009811995	0.99999999999996	0.821706918117932	8309/4312/5743	3
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3/1485	13/6030	0.656263009811995	0.99999999999996	0.821706918117932	3685/3690/7134	3
WP3958	GPR40 pathway	3/1485	13/6030	0.656263009811995	0.99999999999996	0.821706918117932	23236/5333/5336	3
WP692	Sulfation biotransformation reaction	3/1485	13/6030	0.656263009811995	0.99999999999996	0.821706918117932	6817/6799/6822	3
WP2371	Parkinson's disease pathway	8/1485	35/6030	0.659871808623278	0.99999999999996	0.821706918117932	898/1644/120892/5600/6300/9627/23208/9246	8
WP357	Fatty acid biosynthesis	5/1485	22/6030	0.662296043152715	0.99999999999996	0.821706918117932	2180/2182/1891/55268/6319	5
WP1742	TP53 network	4/1485	18/6030	0.681782450158531	0.99999999999996	0.821706918117932	1029/5366/8626/7161	4
WP2525	Trans-sulfuration and one-carbon metabolism	6/1485	27/6030	0.685927187867777	0.99999999999996	0.821706918117932	275/875/25902/10797/26227/29968	6
WP2643	Nanoparticle-mediated activation of receptor signaling	6/1485	27/6030	0.685927187867777	0.99999999999996	0.821706918117932	10000/1277/3672/5600/6300/5293	6
WP3869	Cannabinoid receptor signaling	6/1485	27/6030	0.685927187867777	0.99999999999996	0.821706918117932	1557/1559/1576/5600/6300/5577	6
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	6/1485	27/6030	0.685927187867777	0.99999999999996	0.821706918117932	1959/3315/26353/4359/5865/79628	6
WP5121	Sphingolipid metabolism in senescence	6/1485	27/6030	0.685927187867777	0.99999999999996	0.821706918117932	23236/5579/1901/9294/8877/7015	6
WP2272	Pathogenic Escherichia coli infection	11/1485	49/6030	0.691597598160047	0.99999999999996	0.821706918117932	10095/9076/2534/3059/23643/7099/79861/7280/10381/84617/7454	11
WP4255	Non-small cell lung cancer	16/1485	71/6030	0.703096353517954	0.99999999999996	0.821706918117932	10000/841/1029/1381/1382/3718/5163/5293/8503/5336/5579/5915/83593/6258/6774/6776	16
WP5205	Clock-controlled autophagy in bone metabolism	16/1485	71/6030	0.703096353517954	0.99999999999996	0.821706918117932	393/8553/651/653/8646/115908/1513/22943/3569/3717/4772/10507/5176/4982/7480/7474	16
WP4357	NRF2-ARE regulation	5/1485	23/6030	0.70320671665235	0.99999999999996	0.821706918117932	1051/2534/2939/1728/23657	5
WP4483	Relationship between inflammation, COX-2 and EGFR	5/1485	23/6030	0.70320671665235	0.99999999999996	0.821706918117932	10000/4312/5293/51365/5743	5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5/1485	23/6030	0.70320671665235	0.99999999999996	0.821706918117932	3553/3569/10135/23057/6513	5
WP4540	Hippo signaling regulation pathways	19/1485	84/6030	0.706287013090397	0.99999999999996	0.821706918117932	1009/1014/1001/1003/1004/1969/2261/2321/2324/3791/26524/51176/5159/23236/5577/5579/6788/7004/7010	19
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3/1485	14/6030	0.70827768453508	0.99999999999996	0.821706918117932	1466/283120/5366	3
WP49	IL-2 signaling pathway	9/1485	41/6030	0.712021819191184	0.99999999999996	0.821706918117932	2534/3559/3560/3718/9111/9021/6772/6774/6776	9
WP2870	Extracellular vesicle-mediated signaling in recipient cells	6/1485	28/6030	0.721821050140503	0.99999999999996	0.821706918117932	3082/4240/23533/7042/7043/7474	6
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4/1485	19/6030	0.725044170552593	0.99999999999996	0.821706918117932	3091/3939/5163/6513	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4/1485	19/6030	0.725044170552593	0.99999999999996	0.821706918117932	2152/2212/3553/114548	4
WP5181	Roles of ceramides in the development of insulin resistance	4/1485	19/6030	0.725044170552593	0.99999999999996	0.821706918117932	2180/3651/7124/7185	4
WP244	Alpha 6 beta 4 signaling pathway	7/1485	33/6030	0.738335035556373	0.99999999999996	0.821706918117932	3655/284217/3909/3911/3913/3915/3918	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	9/1485	42/6030	0.740341219438444	0.99999999999996	0.821706918117932	330/841/6347/3569/4318/4791/7124/51330/7185	9
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	9/1485	42/6030	0.740341219438444	0.99999999999996	0.821706918117932	72/3689/3690/3694/11184/9448/259230/6788/7004	9
WP4925	Unfolded protein response	5/1485	24/6030	0.740528615099386	0.99999999999996	0.821706918117932	841/3309/3553/5366/7494	5
WP1992	Genes targeted by miRNAs in adipocytes	2/1485	10/6030	0.747698008108876	0.99999999999996	0.821706918117932	2078/2697	2
WP2007	Iron metabolism in placenta	2/1485	10/6030	0.747698008108876	0.99999999999996	0.821706918117932	30061/7036	2
WP2333	Trans-sulfuration pathway	2/1485	10/6030	0.747698008108876	0.99999999999996	0.821706918117932	875/4357	2
WP4259	Disorders of folate metabolism and transport	2/1485	10/6030	0.747698008108876	0.99999999999996	0.821706918117932	10840/113235	2
WP5050	TCA cycle in senescence	2/1485	10/6030	0.747698008108876	0.99999999999996	0.821706918117932	4199/5163	2
WP382	MAPK signaling pathway	48/1485	210/6030	0.751900737099318	0.99999999999996	0.821706918117932	10000/773/775/777/9254/785/994/11221/1844/1846/1849/2246/2255/2259/2247/2252/2254/2261/2316/2318/3310/3315/3552/3553/3554/120892/9064/1326/11184/9448/5600/6300/22808/4772/4791/3164/5155/5159/283748/5778/5880/10125/25780/115727/6788/7042/7043/7124	48
WP5182	Pro-survival signaling of neuroprotectin D1	3/1485	15/6030	0.754012440362908	0.99999999999996	0.821706918117932	330/841/7124	3
WP3972	PDGFR-beta pathway	6/1485	29/6030	0.754750235293766	0.99999999999996	0.821706918117932	3717/5159/5579/6772/6774/6776	6
WP5117	Cohesin complex - Cornelia de Lange syndrome	6/1485	29/6030	0.754750235293766	0.99999999999996	0.821706918117932	9212/113130/983/157570/5347/9985	6
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	17/1485	78/6030	0.759751110781554	0.99999999999996	0.821706918117932	467/80319/22943/8061/11211/283120/51176/5328/5176/6423/6425/64321/7020/7480/7481/7472/7474	17
WP2878	PPAR-alpha pathway	4/1485	20/6030	0.763760027672008	0.99999999999996	0.821706918117932	335/345/983/2168	4
WP1971	Integrated cancer pathway	9/1485	43/6030	0.766700995974146	0.99999999999996	0.821706918117932	641/672/841/994/983/1030/4312/5347/6772	9
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	9/1485	43/6030	0.766700995974146	0.99999999999996	0.821706918117932	10000/775/816/2906/116443/9456/5293/8503/85358	9
WP4223	Ras signaling	36/1485	161/6030	0.777311704614504	0.99999999999996	0.821706918117932	10000/1969/2113/2261/2321/2324/2784/59345/10681/51764/2786/3363/3791/8844/283455/22808/5159/5293/8503/51365/84647/5320/50487/283748/5336/5579/5880/8437/64926/10125/25780/115727/83593/25759/7010/7535	36
WP127	IL-5 signaling pathway	8/1485	39/6030	0.77991187281522	0.99999999999996	0.821706918117932	695/1439/3568/3717/4067/6772/6774/6776	8
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	14/1485	66/6030	0.782840985271953	0.99999999999996	0.821706918117932	2222/2224/3157/3422/3638/3949/23175/4023/4047/4597/6319/10802/9871/6713	14
WP3858	Toll-like receptor signaling related to MyD88	6/1485	30/6030	0.784733206761219	0.99999999999996	0.821706918117932	4791/7096/7097/7099/51311/54106	6
WP254	Apoptosis	18/1485	84/6030	0.789690821771128	0.99999999999996	0.821706918117932	330/332/834/843/841/1029/3002/8739/3659/3662/4049/5366/5551/7124/7133/8626/7161/7185	18
WP4815	Glycosaminoglycan degradation	3/1485	16/6030	0.793781411812658	0.99999999999996	0.821706918117932	10855/3373/8692	3
WP4970	Galanin receptor pathway	3/1485	16/6030	0.793781411812658	0.99999999999996	0.821706918117932	3569/10891/7020	3
WP3527	Pre-implantation embryo	7/1485	35/6030	0.79482448257131	0.99999999999996	0.821706918117932	366/55509/11189/94234/3662/5460/7004	7
WP3679	Cell-type dependent selectivity of CCK2R signaling	2/1485	11/6030	0.795340704640755	0.99999999999996	0.821706918117932	952/23236	2
WP4589	Major receptors targeted by epinephrine and norepinephrine	2/1485	11/6030	0.795340704640755	0.99999999999996	0.821706918117932	196883/150	2
WP4788	Autosomal recessive osteopetrosis pathways	2/1485	11/6030	0.795340704640755	0.99999999999996	0.821706918117932	29887/10312	2
WP4919	Neuroinflammation	2/1485	11/6030	0.795340704640755	0.99999999999996	0.821706918117932	4843/7099	2
WP4947	Nitric oxide metabolism in cystic fibrosis	2/1485	11/6030	0.795340704640755	0.99999999999996	0.821706918117932	4843/4846	2
WP4288	MTHFR deficiency	4/1485	21/6030	0.798084020408395	0.99999999999996	0.821706918117932	55349/56994/2906/259230	4
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	4/1485	21/6030	0.798084020408395	0.99999999999996	0.821706918117932	841/5600/6300/7124	4
WP3941	Oxidative damage response	8/1485	40/6030	0.804446498529125	0.99999999999996	0.821706918117932	715/716/717/721/728/7124/7133/7185	8
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5/1485	26/6030	0.804554785838496	0.99999999999996	0.821706918117932	857/1051/3717/5618/23508	5
WP3851	TLR4 signaling and tolerance	5/1485	26/6030	0.804554785838496	0.99999999999996	0.821706918117932	3569/3635/11213/7099/7124	5
WP2018	RANKL/RANK signaling pathway	11/1485	54/6030	0.81120541835127	0.99999999999996	0.821706918117932	1513/2274/3383/4067/4772/4791/6688/6772/4982/7185/7412	11
WP4844	Influence of laminopathies on Wnt signaling	6/1485	31/6030	0.81184380956209	0.99999999999996	0.821706918117932	27161/1051/8091/51176/6696/7480	6
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	6/1485	31/6030	0.81184380956209	0.99999999999996	0.821706918117932	3283/4318/5163/5293/23236/5579	6
WP710	DNA damage response (only ATM dependent)	22/1485	103/6030	0.812713441931996	0.99999999999996	0.821706918117932	10000/604/1029/8061/3949/51176/197259/4791/5163/5288/5293/8503/23533/5328/5366/5880/6648/7161/7480/7481/7472/7474	22
WP2857	Mesodermal commitment pathway	26/1485	121/6030	0.819537331361839	0.99999999999996	0.821706918117932	90/92/8728/10973/57198/8553/55704/8646/1466/22943/2296/2627/8091/3624/3717/51176/83881/5080/5308/5460/5915/6615/64321/6925/55809/10451	26
WP4290	Metabolic reprogramming in colon cancer	8/1485	41/6030	0.826852481398929	0.99999999999996	0.821706918117932	229/2023/3101/3939/5315/29968/5831/6513	8
WP4830	GDNF/RET signaling axis	3/1485	17/6030	0.828031585903639	0.99999999999996	0.821706918117932	2296/26585/64321	3
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4/1485	22/6030	0.828259126465213	0.99999999999996	0.821706918117932	597/10017/3655/5744	4
WP4806	EGFR tyrosine kinase inhibitor resistance	17/1485	82/6030	0.829391307726078	0.99999999999996	0.821706918117932	10000/2247/2261/3082/3569/3717/3791/22808/3084/5155/5159/5293/8503/5336/5579/25759/6774	17
WP3931	Embryonic stem cell pluripotency pathways	19/1485	91/6030	0.830827494502617	0.99999999999996	0.821706918117932	90/10000/2246/2255/2259/2247/2252/2254/2261/3572/6300/5155/5159/5293/6774/7480/7481/7472/7474	19
WP2533	Glycerophospholipid biosynthetic pathway	5/1485	27/6030	0.831515603559114	0.99999999999996	0.821706918117932	56994/2819/23175/5293/5320	5
WP5038	Mitochondrial immune response to SARS-CoV-2	5/1485	27/6030	0.831515603559114	0.99999999999996	0.821706918117932	1636/59272/185/1514/4791	5
WP2513	Nanoparticle triggered regulated necrosis	2/1485	12/6030	0.834835304842694	0.99999999999996	0.821706918117932	841/7124	2
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/1485	12/6030	0.834835304842694	0.99999999999996	0.821706918117932	22943/6750	2
WP4504	Cysteine and methionine catabolism	2/1485	12/6030	0.834835304842694	0.99999999999996	0.821706918117932	875/4357	2
WP5173	Disorders of galactose metabolism 	2/1485	12/6030	0.834835304842694	0.99999999999996	0.821706918117932	8908/6514	2
WP23	B cell receptor signaling pathway	20/1485	96/6030	0.838692112986559	0.99999999999996	0.821706918117932	604/695/84433/973/27071/2113/2534/3059/3635/3662/7462/4067/11184/118788/5336/5579/5788/5880/25780/7409	20
WP3303	RAC1/PAK1/p38/MMP2 pathway	13/1485	65/6030	0.845385556057622	0.99999999999996	0.821706918117932	285/9068/332/9046/5600/6300/4313/4843/6774/6776/7010/7075/79931	13
WP3658	Wnt/beta-catenin signaling pathway in leukemia	4/1485	23/6030	0.854585949583711	0.99999999999996	0.821706918117932	22943/51176/5371/7704	4
WP3845	Canonical and non-canonical Notch signaling	4/1485	23/6030	0.854585949583711	0.99999999999996	0.821706918117932	51176/4237/4854/4855	4
WP3982	miRNA regulation of p53 pathway in prostate cancer	4/1485	23/6030	0.854585949583711	0.99999999999996	0.821706918117932	841/192668/5366/5054	4
WP3888	VEGFA-VEGFR2 signaling pathway	92/1485	409/6030	0.863989863849504	0.99999999999996	0.821706918117932	23597/8754/9510/56999/301/81575/22899/10973/332/811/813/857/6347/1003/79094/1397/1466/1536/1558/22943/4189/1847/1960/2022/1969/2078/2113/2152/2274/24147/2321/6624/2534/2697/1839/51564/3142/3315/5654/10525/3383/3486/3490/3685/3690/3791/9079/3939/3984/6300/4319/4323/4313/79812/653361/4688/91624/4772/4846/4855/3164/4929/8013/441478/8828/5034/55872/5228/5328/5329/4860/9588/5579/5743/57381/27289/1901/57758/6386/23753/6401/9047/25759/357/6541/6648/6748/6772/6774/7004/8794/81567	92
WP4942	15q13.3 copy number variation syndrome	2/1485	13/6030	0.867302994848275	0.99999999999996	0.821706918117932	1139/2534	2
WP4666	Hepatitis B infection	28/1485	134/6030	0.868657601416292	0.99999999999996	0.821706918117932	10000/332/843/841/64764/84699/9586/1959/1960/3569/3717/3718/5600/6300/4318/4772/5293/8503/5579/6772/6774/6775/6776/7042/7043/7097/7099/7124	28
WP4698	Vitamin D-sensitive calcium signaling in depression	5/1485	29/6030	0.876323081088486	0.99999999999996	0.821706918117932	775/1593/1594/2906/7166	5
WP2828	Bladder cancer	7/1485	39/6030	0.879361766355143	0.99999999999996	0.821706918117932	1029/2261/1839/4312/4313/4318/1890	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	14/1485	72/6030	0.87990310531219	0.99999999999996	0.821706918117932	80319/22943/8061/11211/51176/5328/5176/6423/6425/64321/7480/7481/7472/7474	14
WP5224	2q37 copy number variation syndrome	21/1485	104/6030	0.881424068664301	0.99999999999996	0.821706918117932	10123/10203/1058/1293/6373/27128/27185/55355/3553/79781/3690/547/129807/5133/3651/64284/25992/7124/54575/54657/54578	21
WP4722	Glycerolipids and glycerophospholipids	3/1485	19/6030	0.882075896021423	0.99999999999996	0.821706918117932	56895/56994/80339	3
WP5103	Progeria-associated lipodystrophy	3/1485	19/6030	0.882075896021423	0.99999999999996	0.821706918117932	2200/3763/5965	3
WP51	Regulation of actin cytoskeleton	26/1485	127/6030	0.887092512938227	0.99999999999996	0.821706918117932	50649/9459/1131/81624/2149/2246/2255/2259/2247/2252/2254/2261/3672/3984/22808/4478/5155/5159/5288/5293/8503/23533/5880/7409/7429/7454	26
WP47	Hedgehog signaling pathway	2/1485	14/6030	0.893807213233808	0.99999999999996	0.821706918117932	3549/6469	2
WP53	ID signaling pathway	2/1485	14/6030	0.893807213233808	0.99999999999996	0.821706918117932	898/2004	2
WP143	Fatty acid beta-oxidation	5/1485	30/6030	0.89464105595394	0.99999999999996	0.821706918117932	35/2180/2182/3990/4023	5
WP2363	Gastric cancer network 2	5/1485	30/6030	0.89464105595394	0.99999999999996	0.821706918117932	1297/79075/51316/255488/11065	5
WP3915	Angiopoietin-like protein 8 regulatory pathway	25/1485	125/6030	0.908709951414119	0.99999999999996	0.821706918117932	64240/64241/1576/1734/2203/4023/9064/1326/11184/9448/5600/6300/51085/5105/5288/5293/8503/23433/6196/27330/6319/25759/6567/6513/7068	25
WP314	Fas ligand pathway and stress induction of heat shock proteins	7/1485	41/6030	0.909335319555635	0.99999999999996	0.821706918117932	397/843/841/3315/3552/8767/7124	7
WP1772	Apoptosis modulation and signaling	16/1485	84/6030	0.910156953828723	0.99999999999996	0.821706918117932	597/10017/330/332/664/834/843/841/1029/8739/3554/8682/5366/5783/8794/7133	16
WP428	Wnt signaling	19/1485	98/6030	0.911448897502042	0.99999999999996	0.821706918117932	816/80319/22943/8061/11211/51176/4772/5328/23236/5579/5176/6423/6425/64321/57216/7480/7481/7472/7474	19
WP2037	Prolactin signaling pathway	14/1485	75/6030	0.913413543351356	0.99999999999996	0.821706918117932	2316/2534/3659/3717/4843/5618/6196/8651/9021/6772/6774/6776/7409/7535	14
WP1422	Sphingolipid pathway	4/1485	26/6030	0.91385441419406	0.99999999999996	0.821706918117932	56624/9514/259230/8877	4
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/1485	15/6030	0.915314101367792	0.99999999999996	0.821706918117932	2254/5600	2
WP4962	Airway smooth muscle cell contraction	2/1485	15/6030	0.915314101367792	0.99999999999996	0.821706918117932	952/23236	2
WP4905	1q21.1 copy number variation syndrome	3/1485	21/6030	0.920433691322983	0.99999999999996	0.821706918117932	2330/2697/2702	3
WP2516	ATM signaling pathway	6/1485	37/6030	0.922410449854552	0.99999999999996	0.821706918117932	8120/672/891/898/983/7161	6
WP2359	Parkin-ubiquitin proteasomal system pathway	11/1485	62/6030	0.925569603365282	0.99999999999996	0.821706918117932	834/841/898/3309/3310/9627/79861/7280/10381/84617/9246	11
WP3594	Circadian rhythm genes	32/1485	159/6030	0.925935606847276	0.99999999999996	0.821706918117932	100/134/56938/8553/1141/1390/1644/1960/2155/51738/50865/6928/9456/3363/3569/4543/4547/10135/22871/4843/5371/10891/5551/5593/60675/5730/6097/5054/150094/6532/7166/463	32
WP2112	IL-17 signaling pathway	4/1485	27/6030	0.928174207347964	0.99999999999996	0.821706918117932	1051/3605/3717/6774	4
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2/1485	16/6030	0.932675914161383	0.99999999999996	0.821706918117932	51176/6925	2
WP500	Glycogen synthesis and degradation	6/1485	38/6030	0.9338289494279	0.99999999999996	0.821706918117932	8908/3099/3101/80201/5522/5523	6
WP4482	Vitamin D in inflammatory diseases	3/1485	22/6030	0.934987569984736	0.99999999999996	0.821706918117932	3569/4772/7124	3
WP399	Wnt signaling pathway and pluripotency	16/1485	87/6030	0.93515361233743	0.99999999999996	0.821706918117932	960/8061/11211/3949/51176/120892/4316/5328/5460/5522/5523/5579/7480/7481/7472/7474	16
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5/1485	33/6030	0.936189984523803	0.99999999999996	0.821706918117932	3455/10379/4939/4940/6772	5
WP4150	Wnt signaling in kidney disease	4/1485	28/6030	0.940309534304851	0.99999999999996	0.821706918117932	7480/7481/7472/7474	4
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	1/1485	10/6030	0.940965550643859	0.99999999999996	0.821706918117932	672	1
WP5120	Inclusion body myositis	1/1485	10/6030	0.940965550643859	0.99999999999996	0.821706918117932	4791	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/1485	10/6030	0.940965550643859	0.99999999999996	0.821706918117932	51311	1
WP2038	Microtubule cytoskeleton regulation	7/1485	44/6030	0.942235369099577	0.99999999999996	0.821706918117932	9212/983/2151/11004/3984/6774/10420	7
WP410	Exercise-induced circadian regulation	7/1485	44/6030	0.942235369099577	0.99999999999996	0.821706918117932	1051/50486/2947/3108/3422/11030/10381	7
WP100	Glutathione metabolism	2/1485	17/6030	0.946628491262415	0.99999999999996	0.821706918117932	290/2938	2
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/1485	17/6030	0.946628491262415	0.99999999999996	0.821706918117932	3685/3690	2
WP3871	Valproic acid pathway	1/1485	11/6030	0.95552803524417	0.99999999999996	0.821706918117932	1559	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/1485	11/6030	0.95552803524417	0.99999999999996	0.821706918117932	604	1
WP4313	Ferroptosis	10/1485	61/6030	0.95582024245083	0.99999999999996	0.821706918117932	2180/2182/246/875/1536/1803/2222/3315/30061/23657	10
WP3584	MECP2 and associated Rett syndrome	9/1485	56/6030	0.956036290914957	0.99999999999996	0.821706918117932	604/2247/2289/2530/2892/2893/54715/6750/6890	9
WP4016	DNA IR-damage and cellular response via ATR	13/1485	76/6030	0.95678388084525	0.99999999999996	0.821706918117932	604/672/675/8318/983/63967/9156/2175/2305/5347/5371/353497/5965	13
WP466	DNA replication	6/1485	41/6030	0.959650408524519	0.99999999999996	0.821706918117932	8318/990/8317/55388/4998/23594	6
WP179	Cell cycle	21/1485	115/6030	0.95994224863601	0.99999999999996	0.821706918117932	699/890/891/898/8556/991/994/8318/990/8317/983/1029/1030/10459/4998/23594/9088/5347/7042/7043/7272	21
WP4906	3q29 copy number variation syndrome	8/1485	52/6030	0.962814649670483	0.99999999999996	0.821706918117932	84984/3091/375387/80235/8503/30061/123264/6776	8
WP2636	Common pathways underlying drug addiction	4/1485	31/6030	0.966346076149247	0.99999999999996	0.821706918117932	72/2892/2893/5579	4
WP186	Homologous recombination	1/1485	12/6030	0.966500101644304	0.99999999999996	0.821706918117932	675	1
WP2023	Cell differentiation - expanded index	1/1485	12/6030	0.966500101644304	0.99999999999996	0.821706918117932	6774	1
WP2290	RalA downstream regulated genes	1/1485	12/6030	0.966500101644304	0.99999999999996	0.821706918117932	5880	1
WP3933	Kennedy pathway from sphingolipids	1/1485	12/6030	0.966500101644304	0.99999999999996	0.821706918117932	56994	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/1485	19/6030	0.966705226628895	0.99999999999996	0.821706918117932	2683/8877	2
WP1403	AMP-activated protein kinase (AMPK) signaling	9/1485	58/6030	0.967290185868784	0.99999999999996	0.821706918117932	147/890/891/126129/5209/5293/8503/23236/55437	9
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	8/1485	53/6030	0.968170759184312	0.99999999999996	0.821706918117932	843/841/3627/3458/9636/5600/6300/7124	8
WP4321	Thermogenesis	17/1485	98/6030	0.968435206211038	0.99999999999996	0.821706918117932	2180/2182/196883/656/126129/64764/84699/9586/2641/152831/5600/6300/4881/10891/5593/6196/27330	17
WP4249	Hedgehog signaling pathway	5/1485	37/6030	0.968647657924197	0.99999999999996	0.821706918117932	91653/2619/64399/3549/6469	5
WP524	G13 signaling pathway	5/1485	37/6030	0.968647657924197	0.99999999999996	0.821706918117932	397/398/3984/5293/7454	5
WP2853	Endoderm differentiation	21/1485	118/6030	0.971164662531019	0.99999999999996	0.821706918117932	10973/57198/22943/1844/1846/1847/2627/6928/3915/51176/10459/83881/5460/5744/23682/64321/6772/30009/6925/55809/10451	21
WP2586	Aryl hydrocarbon receptor pathway	6/1485	43/6030	0.971363129114191	0.99999999999996	0.821706918117932	1545/4023/135112/1728/5743/7124	6
WP2507	Nanomaterial induced apoptosis	2/1485	20/6030	0.973788566598038	0.99999999999996	0.821706918117932	841/5551	2
WP4725	Sphingolipid metabolism overview	2/1485	20/6030	0.973788566598038	0.99999999999996	0.821706918117932	259230/8877	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	13/1485	80/6030	0.974449008400241	0.99999999999996	0.821706918117932	183/1906/2247/51564/3572/3084/5293/8503/5320/5579/6774/7124/7474	13
WP35	G protein signaling pathways	14/1485	85/6030	0.974502877527721	0.99999999999996	0.821706918117932	196883/9472/9465/2769/2784/10681/51764/2786/3760/5153/5137/5142/5577/5579	14
WP4657	22q11.2 copy number variation syndrome	15/1485	90/6030	0.974665187758858	0.99999999999996	0.821706918117932	8854/8659/8318/8646/9076/56603/2255/2296/4942/5308/5347/5625/6097/6469/7450	15
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	1/1485	13/6030	0.97476652721064	0.99999999999996	0.821706918117932	25939	1
WP5037	Riboflavin and CoQ disorders	1/1485	13/6030	0.97476652721064	0.99999999999996	0.821706918117932	55065	1
WP4971	Phosphoinositides metabolism	6/1485	44/6030	0.975962249116498	0.99999999999996	0.821706918117932	3635/5288/5293/23236/5333/5336	6
WP3996	Ethanol effects on histone modifications	3/1485	27/6030	0.977329651155114	0.99999999999996	0.821706918117932	126/8854/51564	3
WP5102	Familial partial lipodystrophy (FPLD)	3/1485	27/6030	0.977329651155114	0.99999999999996	0.821706918117932	10365/4023/5396	3
WP4932	7q11.23 copy number variation syndrome	14/1485	86/6030	0.977666033028275	0.99999999999996	0.821706918117932	64756/695/9076/2006/2200/7462/3984/51085/3084/5313/6616/9246/155382/7472	14
WP2526	PDGF pathway	5/1485	39/6030	0.978363094257962	0.99999999999996	0.821706918117932	5155/5159/6772/6774/7409	5
WP5085	Vasopressin-regulated water reabsorption	5/1485	39/6030	0.978363094257962	0.99999999999996	0.821706918117932	397/398/64764/84699/9586	5
WP4726	Sphingolipid metabolism: integrated pathway	2/1485	21/6030	0.97940486925857	0.99999999999996	0.821706918117932	259230/8877	2
WP4928	MAPK pathway in congenital thyroid cancer	1/1485	14/6030	0.980994166747319	0.99999999999996	0.821706918117932	8844	1
WP313	Hepatocyte growth factor receptor signaling	4/1485	34/6030	0.98146613551432	0.99999999999996	0.821706918117932	3082/3672/11184/6774	4
WP4312	Rett syndrome causing genes	5/1485	40/6030	0.982088218470103	0.99999999999996	0.821706918117932	3766/23314/85358/23224/6925	5
WP45	G1 to S cell cycle control	9/1485	62/6030	0.982353252768523	0.99999999999996	0.821706918117932	891/898/8318/983/1029/1030/84699/4998/23594	9
WP4659	Gastrin signaling pathway	18/1485	108/6030	0.983138128543968	0.99999999999996	0.821706918117932	302/330/332/960/1029/1113/9076/2534/51564/3067/3717/4316/8503/5743/5054/6774/6925/7032	18
WP4566	Translation inhibitors in chronically activated PDGFRA cells	6/1485	46/6030	0.983177954356475	0.99999999999996	0.821706918117932	10000/27250/5163/8503/11040/6196	6
WP4686	Leucine, isoleucine and valine metabolism	2/1485	22/6030	0.983846599185953	0.99999999999996	0.821706918117932	586/587	2
WP4262	Breast cancer pathway	22/1485	129/6030	0.985845716476725	0.99999999999996	0.821706918117932	10000/672/675/2246/2255/2247/2252/2254/2324/11211/23493/51176/4791/4854/4855/5293/8503/25759/7480/7481/7472/7474	22
WP3959	DNA IR-double strand breaks and cellular response via ATM	7/1485	53/6030	0.986959841361286	0.99999999999996	0.821706918117932	641/672/675/1029/9156/6788/7161	7
WP4205	MET in type 1 papillary renal cell carcinoma	7/1485	53/6030	0.986959841361286	0.99999999999996	0.821706918117932	10000/2113/3082/3718/5293/8503/6774	7
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4/1485	36/6030	0.987687798809493	0.99999999999996	0.821706918117932	3488/5163/10891/8744	4
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/1485	30/6030	0.988288979128289	0.99999999999996	0.821706918117932	4846/5163/8503	3
WP195	IL-1 signaling pathway	7/1485	54/6030	0.989066229911008	0.99999999999996	0.821706918117932	6347/3552/3553/3554/3556/3656/11213	7
WP1545	miRNAs involved in DNA damage response	1/1485	16/6030	0.989219579043869	0.99999999999996	0.821706918117932	898	1
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	1/1485	16/6030	0.989219579043869	0.99999999999996	0.821706918117932	5105	1
WP481	Insulin signaling	27/1485	156/6030	0.989769959813475	0.99999999999996	0.821706918117932	30846/5167/9064/1326/11184/9448/5600/6300/5288/5293/8503/5579/5880/5967/57381/23433/6196/27330/10110/10603/25759/6513/6616/8651/9021/57761/7494	27
WP4521	Glycosylation and related congenital defects	2/1485	24/6030	0.990110643284026	0.99999999999996	0.821706918117932	2683/79644	2
WP231	TNF-alpha signaling pathway	14/1485	92/6030	0.990257740586494	0.99999999999996	0.821706918117932	330/841/6347/3569/8844/283455/1326/4791/5347/6401/7124/7128/7133/7185	14
WP2637	Interleukin-1 (IL-1) structural pathway	6/1485	49/6030	0.990305836207326	0.99999999999996	0.821706918117932	3552/3554/3556/3656/1326/5600	6
WP2261	Glioblastoma signaling pathways	12/1485	82/6030	0.990785240602184	0.99999999999996	0.821706918117932	10000/672/675/898/1029/1030/54206/5159/5288/5293/5336/5579	12
WP4155	Endometrial cancer	8/1485	61/6030	0.991498746654285	0.99999999999996	0.821706918117932	10000/1496/2246/2247/2261/51176/5293/8503	8
WP4674	Head and neck squamous cell carcinoma	10/1485	72/6030	0.991627980992226	0.99999999999996	0.821706918117932	84962/10000/841/1029/54541/2261/4791/23533/7015/8626	10
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5/1485	44/6030	0.991763397581806	0.99999999999996	0.821706918117932	3309/26051/84152/79660/7494	5
WP391	Mitochondrial gene expression	1/1485	17/6030	0.99188152203021	0.99999999999996	0.821706918117932	10891	1
WP5200	Dravet syndrome	1/1485	17/6030	0.99188152203021	0.99999999999996	0.821706918117932	5600	1
WP3965	Lipid metabolism pathway	2/1485	25/6030	0.992279041189518	0.99999999999996	0.821706918117932	10000/5577	2
WP4022	Pyrimidine metabolism	11/1485	79/6030	0.99355183791266	0.99999999999996	0.821706918117932	1503/5167/953/956/56953/10622/6241/7083/1890/7371/7378	11
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	1/1485	18/6030	0.993886501206185	0.99999999999996	0.821706918117932	55872	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/1485	18/6030	0.993886501206185	0.99999999999996	0.821706918117932	22808	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/1485	18/6030	0.993886501206185	0.99999999999996	0.821706918117932	3363	1
WP3981	miRNA regulation of prostate cancer signaling pathways	3/1485	33/6030	0.99405205117597	0.99999999999996	0.821706918117932	10000/354/5159	3
WP4874	CAMKK2 pathway	3/1485	33/6030	0.99405205117597	0.99999999999996	0.821706918117932	1131/3383/7412	3
WP2446	Retinoblastoma gene in cancer	12/1485	86/6030	0.995029160597578	0.99999999999996	0.821706918117932	54443/890/891/898/994/8318/8317/983/24137/4998/6241/7272	12
WP400	p38 MAPK signaling pathway	3/1485	34/6030	0.995270043014194	0.99999999999996	0.821706918117932	3315/6772/7042	3
WP384	Apoptosis modulation by HSP70	1/1485	19/6030	0.995396572016035	0.99999999999996	0.821706918117932	841	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/1485	19/6030	0.995396572016035	0.99999999999996	0.821706918117932	10125	1
WP2795	Cardiac hypertrophic response	6/1485	53/6030	0.995472271626121	0.99999999999996	0.821706918117932	2247/51564/11184/3084/5320/7124	6
WP268	Notch signaling	4/1485	41/6030	0.995718273639431	0.99999999999996	0.821706918117932	151636/4242/4854/4855	4
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/1485	28/6030	0.996353524760845	0.99999999999996	0.821706918117932	841/5153	2
WP366	TGF-beta signaling pathway	20/1485	130/6030	0.996485103873032	0.99999999999996	0.821706918117932	467/857/983/1030/1278/2113/50943/3673/3690/3726/11184/4312/4321/5163/5371/150094/6498/7015/3371/6935	20
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/1485	20/6030	0.996533835459087	0.99999999999996	0.821706918117932	3002	1
WP3878	ATM signaling in development and disease 	4/1485	42/6030	0.996551304838513	0.99999999999996	0.821706918117932	9212/699/983/3315	4
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4/1485	42/6030	0.996551304838513	0.99999999999996	0.821706918117932	196883/23224/7042/7043	4
WP673	ErbB signaling pathway	11/1485	83/6030	0.996630255309485	0.99999999999996	0.821706918117932	10000/816/1839/3084/145957/5293/8503/5336/5579/25759/6776	11
WP363	Wnt signaling pathway	5/1485	49/6030	0.997007981561958	0.99999999999996	0.821706918117932	2697/51176/5579/6925/7010	5
WP2447	Amyotrophic lateral sclerosis (ALS)	3/1485	36/6030	0.997022163056535	0.99999999999996	0.821706918117932	834/5630/7124	3
WP4549	Fragile X syndrome	14/1485	101/6030	0.997464634094626	0.99999999999996	0.821706918117932	27161/7915/816/1029/1759/1979/54869/2534/80852/9456/4318/5163/23236/6566	14
WP707	DNA damage response	7/1485	62/6030	0.997494521828695	0.99999999999996	0.821706918117932	672/841/891/898/983/5366/5371	7
WP4685	Melanoma	7/1485	63/6030	0.997930965852847	0.99999999999996	0.821706918117932	10000/1029/2113/3791/5293/8503/25759	7
WP61	Notch signaling pathway	6/1485	57/6030	0.997940869029236	0.99999999999996	0.821706918117932	23493/3091/3717/4854/4855/6774	6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	20/1485	134/6030	0.997979738077556	0.99999999999996	0.821706918117932	249/55816/1959/2534/2562/2892/3717/3738/3781/8844/84894/653361/4688/10603/25759/6696/6772/6774/6776/10451	20
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	1/1485	22/6030	0.998035221130216	0.99999999999996	0.821706918117932	51176	1
WP2034	Leptin signaling pathway	9/1485	75/6030	0.998056339474389	0.99999999999996	0.821706918117932	2534/3553/3557/3717/4846/5336/9021/6772/6774	9
WP4263	Pancreatic adenocarcinoma pathway	11/1485	87/6030	0.998279254045239	0.99999999999996	0.821706918117932	10000/9459/675/1029/5293/8503/5880/6772/6774/7042/7043	11
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2/1485	31/6030	0.99829473559285	0.99999999999996	0.821706918117932	51564/4772	2
WP5180	DYRK1A	6/1485	58/6030	0.998315397835306	0.99999999999996	0.821706918117932	273/1759/2247/3092/26524/4772	6
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	8/1485	70/6030	0.998319256723058	0.99999999999996	0.821706918117932	10000/332/51176/5366/5743/5880/7042/7043	8
WP531	DNA mismatch repair	1/1485	23/6030	0.998520856386812	0.99999999999996	0.821706918117932	9156	1
WP437	EGF/EGFR signaling pathway	24/1485	157/6030	0.998571183332914	0.99999999999996	0.821706918117932	50807/6790/857/1759/9046/54206/2697/3635/3717/11184/4605/4846/5359/5579/7837/6196/9047/6456/6772/6774/6776/7291/7409/10451	24
WP183	Proteasome degradation	6/1485	59/6030	0.998623754947393	0.99999999999996	0.821706918117932	3134/3458/5684/5696/5698/5721	6
WP5202	Alstrom syndrome	2/1485	32/6030	0.998678897018115	0.99999999999996	0.821706918117932	84984/26052	2
WP1530	miRNA regulation of DNA damage response	7/1485	66/6030	0.998844745562744	0.99999999999996	0.821706918117932	672/841/891/898/983/5366/5371	7
WP4949	16p11.2 proximal deletion syndrome	7/1485	67/6030	0.999051298168697	0.99999999999996	0.821706918117932	283897/841/11151/8448/3486/4478/23475	7
WP1471	Target of rapamycin (TOR) signaling	2/1485	35/6030	0.999388798900694	0.99999999999996	0.821706918117932	54541/3422	2
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	6/1485	64/6030	0.999509001383072	0.99999999999996	0.821706918117932	898/3717/23236/6772/6774/7253	6
WP4204	Tumor suppressor activity of SMARCB1	1/1485	27/6030	0.999525146625436	0.99999999999996	0.821706918117932	1029	1
WP623	Oxidative phosphorylation	2/1485	36/6030	0.99952801277388	0.99999999999996	0.821706918117932	3002/56901	2
WP138	Androgen receptor signaling pathway	9/1485	85/6030	0.999698495861968	0.99999999999996	0.821706918117932	672/811/857/898/2274/2316/354/8431/6774	9
WP3676	BDNF-TrkB signaling	1/1485	29/6030	0.99973103763717	0.99999999999996	0.821706918117932	9456	1
WP722	Serotonin HTR1 group and FOS pathway	1/1485	29/6030	0.99973103763717	0.99999999999996	0.821706918117932	10125	1
WP4396	Nonalcoholic fatty liver disease	17/1485	137/6030	0.999894146835249	0.99999999999996	0.821706918117932	10000/841/6347/84701/3552/3553/3569/51085/56901/9971/5293/8503/5313/9021/7124/7412/7494	17
WP3651	Pathways affected in adenoid cystic carcinoma	4/1485	58/6030	0.999909100750317	0.99999999999996	0.821706918117932	672/93986/4613/29128	4
WP422	MAPK cascade	1/1485	33/6030	0.999913767716437	0.99999999999996	0.821706918117932	6300	1
WP2369	Histone modifications	1/1485	35/6030	0.999951189176805	0.99999999999996	0.821706918117932	80854	1
WP2059	Alzheimer's disease and miRNA effects	32/1485	229/6030	0.999981126449538	0.99999999999996	0.821706918117932	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/407024/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	32
WP107	Translation factors	2/1485	49/6030	0.999984483001541	0.99999999999996	0.821706918117932	1917/1979	2
WP3680	Physico-chemical features and toxicity-associated pathways	3/1485	58/6030	0.999986113945149	0.99999999999996	0.821706918117932	11211/6776/7481	3
WP5124	Alzheimer's disease	31/1485	226/6030	0.999986571005359	0.99999999999996	0.821706918117932	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	31
WP405	Eukaryotic transcription initiation	1/1485	41/6030	0.999991159390514	0.99999999999996	0.821706918117932	2966	1
WP4753	Nucleotide excision repair	1/1485	43/6030	0.99999500027139	0.99999999999996	0.821706918117932	2966	1
WP4656	Joubert syndrome	4/1485	71/6030	0.999996017887264	0.99999999999996	0.821706918117932	27077/2316/5145/6469	4
WP1541	Energy metabolism	1/1485	44/6030	0.999996240391147	0.99999999999996	0.821706918117932	10891	1
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	2/1485	57/6030	0.999998174397336	0.99999999999996	0.821706918117932	672/2966	2
WP4536	Genes related to primary cilium development (based on CRISPR)	4/1485	88/6030	0.999999942832165	0.99999999999996	0.821706918117932	27077/23552/84984/51715	4
WP4946	DNA repair pathways, full network	6/1485	112/6030	0.999999991855045	0.99999999999996	0.821706918117932	672/675/9156/2175/2187/2966	6
WP477	Cytoplasmic ribosomal proteins	2/1485	86/6030	0.999999999330954	0.99999999999996	0.821706918117932	6196/27330	2
WP4803	Ciliopathies	8/1485	138/6030	0.999999999375053	0.99999999999996	0.821706918117932	122481/27077/10309/84984/1259/1768/4751/51715	8
WP4352	Ciliary landscape	11/1485	201/6030	0.99999999999996	0.99999999999996	0.821706918117932	26286/875/9859/30845/128239/3934/55388/2040/7020/339488/7431	11
